|
G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
multiple interactions increases expression
|
ISO
|
Noscapine promotes the reaction [Cisplatin results in increased expression of BAX protein] Noscapine results in increased expression of BAX protein
|
CTD |
PMID:20674069 |
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
|
|
G
|
Bcl2
|
BCL2, apoptosis regulator
|
decreases expression multiple interactions
|
ISO
|
Noscapine results in decreased expression of BCL2 protein Noscapine promotes the reaction [Cisplatin results in decreased expression of BCL2 protein]
|
CTD |
PMID:20674069 |
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
|
|
G
|
Birc5
|
baculoviral IAP repeat-containing 5
|
decreases response to substance increases expression decreases expression multiple interactions
|
ISO
|
BIRC5 protein results in decreased susceptibility to Noscapine Noscapine results in increased expression of BIRC5 mRNA; Noscapine results in increased expression of BIRC5 protein Noscapine results in decreased expression of BIRC5 protein Noscapine promotes the reaction [Cisplatin results in decreased expression of BIRC5 protein]
|
CTD |
PMID:20674069 PMID:22848370 |
|
NCBI chr10:103,567,369...103,580,069
Ensembl chr10:103,572,080...103,582,155
|
|
G
|
Casp3
|
caspase 3
|
multiple interactions increases activity
|
ISO
|
[Noscapine co-treated with Cisplatin] results in increased cleavage of CASP3 protein; Noscapine promotes the reaction [Cisplatin results in increased expression of and results in increased cleavage of CASP3 protein]; Noscapine results in increased expression of and results in increased cleavage of CASP3 protein Noscapine results in increased activity of CASP3 protein
|
CTD |
PMID:20674069 PMID:22848370 |
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
G
|
Casp9
|
caspase 9
|
multiple interactions
|
ISO
|
Noscapine promotes the reaction [Cisplatin results in increased expression of and results in increased cleavage of CASP9 protein]; Noscapine results in increased expression of and results in increased cleavage of CASP9 protein
|
CTD |
PMID:20674069 |
|
Ensembl chr 5:159,391,188...159,409,648
|
|
G
|
Cdkn1a
|
cyclin-dependent kinase inhibitor 1A
|
multiple interactions increases expression
|
ISO
|
Noscapine promotes the reaction [Cisplatin results in increased expression of CDKN1A protein] Noscapine results in increased expression of CDKN1A protein
|
CTD |
PMID:20674069 |
|
NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969
|
|
G
|
Cyp1a1
|
cytochrome P450, family 1, subfamily a, polypeptide 1
|
multiple interactions
|
ISO
|
Noscapine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein]
|
CTD |
PMID:18493746 |
|
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012
|
|
G
|
Hif1a
|
hypoxia inducible factor 1 subunit alpha
|
multiple interactions
|
ISO
|
Noscapine results in increased degradation of and results in decreased expression of and results in decreased activity of HIF1A protein
|
CTD |
PMID:16596621 |
|
NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:98,359,910...98,405,323
|
|
G
|
Parp1
|
poly (ADP-ribose) polymerase 1
|
increases cleavage
|
ISO
|
Noscapine results in increased cleavage of PARP1 protein
|
CTD |
PMID:22848370 |
|
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:94,839,433...94,871,567
|
|
G
|
Slc22a2
|
solute carrier family 22 member 2
|
multiple interactions
|
ISO
|
Noscapine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium]
|
CTD |
PMID:21599003 |
|
NCBI chr 1:50,668,817...50,711,019
Ensembl chr 1:50,668,817...50,711,019
|
|
G
|
Tp53
|
tumor protein p53
|
multiple interactions increases expression
|
ISO
|
Noscapine promotes the reaction [Cisplatin results in increased expression of TP53 protein]; Noscapine results in increased expression of and results in increased phosphorylation of TP53 protein Noscapine results in increased expression of TP53 protein
|
CTD |
PMID:20674069 PMID:22848370 |
|
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299
|
|
G
|
Vegfa
|
vascular endothelial growth factor A
|
decreases secretion
|
ISO
|
Noscapine results in decreased secretion of VEGFA protein
|
CTD |
PMID:16596621 |
|
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194
|
|
|
G
|
Apoe
|
apolipoprotein E
|
multiple interactions
|
ISO
|
APOE gene mutant form promotes the reaction [Arachidonic Acid results in increased abundance of 11-dehydro-thromboxane B2]; Aspirin inhibits the reaction [APOE gene mutant form promotes the reaction [Arachidonic Acid results in increased abundance of 11-dehydro-thromboxane B2]]; dazoxiben inhibits the reaction [APOE gene mutant form promotes the reaction [Arachidonic Acid results in increased abundance of 11-dehydro-thromboxane B2]]; tempol inhibits the reaction [APOE gene mutant form promotes the reaction [Arachidonic Acid results in increased abundance of 11-dehydro-thromboxane B2]]
|
CTD |
PMID:20530721 |
|
NCBI chr 1:88,481,889...88,485,816
Ensembl chr 1:88,481,385...88,485,855
|
|
G
|
Ldlr
|
low density lipoprotein receptor
|
multiple interactions
|
ISO
|
Aspirin inhibits the reaction [LDLR gene mutant form promotes the reaction [Arachidonic Acid results in increased abundance of 11-dehydro-thromboxane B2]]; dazoxiben inhibits the reaction [LDLR gene mutant form promotes the reaction [Arachidonic Acid results in increased abundance of 11-dehydro-thromboxane B2]]; LDLR gene mutant form promotes the reaction [Arachidonic Acid results in increased abundance of 11-dehydro-thromboxane B2]; tempol inhibits the reaction [LDLR gene mutant form promotes the reaction [Arachidonic Acid results in increased abundance of 11-dehydro-thromboxane B2]]
|
CTD |
PMID:20530721 |
|
NCBI chr 8:28,546,191...28,569,075
Ensembl chr 8:28,546,146...28,570,675
|
|
|
G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
increases expression
|
ISO
|
alborixin results in increased expression of BAX protein
|
CTD |
PMID:27378626 |
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
|
|
G
|
Bcl2
|
BCL2, apoptosis regulator
|
decreases expression
|
ISO
|
alborixin results in decreased expression of BCL2 protein
|
CTD |
PMID:27378626 |
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
|
|
G
|
Casp3
|
caspase 3
|
increases cleavage
|
ISO
|
alborixin results in increased cleavage of CASP3 protein
|
CTD |
PMID:27378626 |
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
G
|
Casp8
|
caspase 8
|
increases activity
|
ISO
|
alborixin results in increased activity of CASP8 protein
|
CTD |
PMID:27378626 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:67,758,033...67,806,699
|
|
G
|
Casp9
|
caspase 9
|
increases activity
|
ISO
|
alborixin results in increased activity of CASP9 protein
|
CTD |
PMID:27378626 |
|
Ensembl chr 5:159,391,188...159,409,648
|
|
G
|
Parp1
|
poly (ADP-ribose) polymerase 1
|
increases cleavage
|
ISO
|
alborixin results in increased cleavage of PARP1 protein
|
CTD |
PMID:27378626 |
|
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:94,839,433...94,871,567
|
|
|
G
|
Fkbp1a
|
FKBP prolyl isomerase 1A
|
multiple interactions
|
ISO EXP
|
immunomycin inhibits the reaction [Sirolimus binds to FKBP1A protein]
|
CTD |
PMID:7503980 PMID:7532117 |
|
NCBI chr 3:140,040,359...140,060,107
Ensembl chr 3:160,500,726...160,524,233
|
|
G
|
Mapt
|
microtubule-associated protein tau
|
multiple interactions
|
EXP ISO
|
[Okadaic Acid co-treated with immunomycin] results in increased phosphorylation of MAPT protein
|
CTD |
PMID:7723735 |
|
NCBI chr10:89,638,618...89,736,108
Ensembl chr10:89,638,599...89,736,108
|
|
|
G
|
Acp5
|
acid phosphatase 5, tartrate resistant
|
decreases expression multiple interactions
|
ISO
|
azadirachtin results in decreased expression of ACP5 mRNA azadirachtin inhibits the reaction [Estrogens deficiency results in increased expression of ACP5 mRNA]
|
CTD |
PMID:31225646 |
|
NCBI chr 8:20,663,984...20,670,604
Ensembl chr 8:28,939,985...28,943,929
|
|
G
|
Apaf1
|
apoptotic peptidase activating factor 1
|
increases expression
|
ISO
|
azadirachtin results in increased expression of APAF1 protein
|
CTD |
PMID:20429769 |
|
NCBI chr 7:27,381,392...27,466,772
Ensembl chr 7:27,381,855...27,466,772
|
|
G
|
Bad
|
BCL2-associated agonist of cell death
|
increases expression
|
ISO
|
azadirachtin results in increased expression of BAD mRNA
|
CTD |
PMID:20429769 |
|
NCBI chr 1:213,562,719...213,572,034
Ensembl chr 1:213,562,187...213,572,034
|
|
G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
increases expression
|
ISO
|
azadirachtin results in increased expression of BAX mRNA
|
CTD |
PMID:20429769 |
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
|
|
G
|
Bcl2
|
BCL2, apoptosis regulator
|
decreases expression
|
ISO
|
azadirachtin results in decreased expression of BCL2 mRNA; azadirachtin results in decreased expression of BCL2 protein
|
CTD |
PMID:20429769 |
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
|
|
G
|
Bcl2l1
|
Bcl2-like 1
|
decreases expression
|
ISO
|
azadirachtin results in decreased expression of BCL2L1 mRNA
|
CTD |
PMID:20429769 |
|
NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:161,745,540...161,764,907 Ensembl chr 1:161,745,540...161,764,907
|
|
G
|
Bglap
|
bone gamma-carboxyglutamate protein
|
multiple interactions
|
ISO
|
azadirachtin inhibits the reaction [Estrogens deficiency results in increased expression of BGLAP protein]
|
CTD |
PMID:31225646 |
|
NCBI chr 2:176,136,341...176,137,318
Ensembl chr 2:176,136,341...176,137,318
|
|
G
|
Bid
|
BH3 interacting domain death agonist
|
increases expression
|
ISO
|
azadirachtin results in increased expression of BID mRNA
|
CTD |
PMID:20429769 |
|
NCBI chr 4:155,785,366...155,808,775
Ensembl chr 4:155,785,377...155,808,275
|
|
G
|
Birc5
|
baculoviral IAP repeat-containing 5
|
decreases expression
|
ISO
|
azadirachtin results in decreased expression of BIRC5 protein
|
CTD |
PMID:20429769 |
|
NCBI chr10:103,567,369...103,580,069
Ensembl chr10:103,572,080...103,582,155
|
|
G
|
Bmp2
|
bone morphogenetic protein 2
|
increases expression
|
ISO
|
azadirachtin results in increased expression of BMP2 mRNA; azadirachtin results in increased expression of BMP2 protein
|
CTD |
PMID:31225646 |
|
NCBI chr 3:141,264,648...141,275,416
Ensembl chr 3:141,264,646...141,274,760
|
|
G
|
Casp3
|
caspase 3
|
increases expression
|
ISO
|
azadirachtin results in increased expression of CASP3 mRNA; azadirachtin results in increased expression of CASP3 protein
|
CTD |
PMID:20429769 |
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
G
|
Casp6
|
caspase 6
|
increases expression
|
ISO
|
azadirachtin results in increased expression of CASP6 protein
|
CTD |
PMID:20429769 |
|
NCBI chr 2:221,140,287...221,152,727
Ensembl chr 2:221,140,256...221,152,726
|
|
G
|
Casp8
|
caspase 8
|
increases expression
|
ISO
|
azadirachtin results in increased expression of CASP8 protein
|
CTD |
PMID:20429769 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:67,758,033...67,806,699
|
|
G
|
Casp9
|
caspase 9
|
increases expression
|
ISO
|
azadirachtin results in increased expression of CASP9 mRNA; azadirachtin results in increased expression of CASP9 protein
|
CTD |
PMID:20429769 |
|
Ensembl chr 5:159,391,188...159,409,648
|
|
G
|
Ccnd1
|
cyclin D1
|
decreases expression
|
ISO
|
azadirachtin results in decreased expression of CCND1 mRNA
|
CTD |
PMID:20429769 |
|
NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810
|
|
G
|
Cdkn1a
|
cyclin-dependent kinase inhibitor 1A
|
increases expression
|
ISO
|
azadirachtin results in increased expression of CDKN1A mRNA; azadirachtin results in increased expression of CDKN1A protein
|
CTD |
PMID:20429769 |
|
NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969
|
|
G
|
Cycs
|
cytochrome c, somatic
|
increases expression affects localization
|
ISO
|
azadirachtin results in increased expression of CYCS mRNA azadirachtin affects the localization of CYCS protein
|
CTD |
PMID:20429769 |
|
NCBI chr 4:80,982,667...80,984,767
Ensembl chr 4:80,982,668...80,984,816 Ensembl chr18:80,982,668...80,984,816
|
|
G
|
Esr1
|
estrogen receptor 1
|
increases expression multiple interactions affects binding
|
ISO
|
azadirachtin results in increased expression of ESR1 mRNA; azadirachtin results in increased expression of ESR1 protein 1,3-bis(4-hydroxyphenyl)-4-methyl-5-(4-(2-piperidinylethoxy)phenol)-1H-pyrazole inhibits the reaction [azadirachtin results in increased expression of ESR1 mRNA]; 1,3-bis(4-hydroxyphenyl)-4-methyl-5-(4-(2-piperidinylethoxy)phenol)-1H-pyrazole inhibits the reaction [azadirachtin results in increased expression of ESR1 protein]; azadirachtin inhibits the reaction [Estrogens deficiency results in decreased expression of ESR1 mRNA]; ESR1 protein promotes the reaction [azadirachtin results in increased expression of RUNX2 mRNA]; ESR1 protein promotes the reaction [azadirachtin results in increased expression of RUNX2 protein] azadirachtin binds to ESR1 protein
|
CTD |
PMID:31225646 |
|
NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354
|
|
G
|
Esr2
|
estrogen receptor 2
|
multiple interactions affects binding increases expression
|
ISO
|
azadirachtin inhibits the reaction [Estrogens deficiency results in decreased expression of ESR2 mRNA] azadirachtin binds to ESR2 protein azadirachtin results in increased expression of ESR2 mRNA; azadirachtin results in increased expression of ESR2 protein
|
CTD |
PMID:31225646 |
|
NCBI chr 6:100,589,553...100,645,240
Ensembl chr 6:100,545,206...100,644,709
|
|
G
|
Ikbkb
|
inhibitor of nuclear factor kappa B kinase subunit beta
|
decreases expression
|
ISO
|
azadirachtin results in decreased expression of IKBKB protein
|
CTD |
PMID:20429769 |
|
NCBI chr16:76,021,968...76,075,717
Ensembl chr16:76,022,008...76,081,911
|
|
G
|
Mapk1
|
mitogen activated protein kinase 1
|
increases phosphorylation
|
ISO
|
azadirachtin results in increased phosphorylation of MAPK1 protein
|
CTD |
PMID:31225646 |
|
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825
|
|
G
|
Mapk3
|
mitogen activated protein kinase 3
|
increases phosphorylation
|
ISO
|
azadirachtin results in increased phosphorylation of MAPK3 protein
|
CTD |
PMID:31225646 |
|
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411
|
|
G
|
Nfkb1
|
nuclear factor kappa B subunit 1
|
decreases expression
|
ISO
|
azadirachtin results in decreased expression of NFKB1 protein
|
CTD |
PMID:20429769 |
|
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:226,689,745...226,783,088
|
|
G
|
Nfkbia
|
NFKB inhibitor alpha
|
decreases expression
|
ISO
|
azadirachtin results in decreased expression of NFKBIA protein modified form
|
CTD |
PMID:20429769 |
|
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:78,593,847...78,597,072
|
|
G
|
Pcna
|
proliferating cell nuclear antigen
|
decreases expression
|
ISO
|
azadirachtin results in decreased expression of PCNA mRNA; azadirachtin results in decreased expression of PCNA protein
|
CTD |
PMID:20429769 |
|
NCBI chr 3:139,951,948...139,955,820
Ensembl chr 3:139,951,941...139,955,901
|
|
G
|
Rela
|
RELA proto-oncogene, NF-kB subunit
|
decreases expression
|
ISO
|
azadirachtin results in decreased expression of RELA protein
|
CTD |
PMID:20429769 |
|
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817
|
|
G
|
Runx2
|
RUNX family transcription factor 2
|
increases expression multiple interactions
|
ISO
|
azadirachtin results in increased expression of RUNX2 mRNA; azadirachtin results in increased expression of RUNX2 protein ESR1 protein promotes the reaction [azadirachtin results in increased expression of RUNX2 mRNA]; ESR1 protein promotes the reaction [azadirachtin results in increased expression of RUNX2 protein]
|
CTD |
PMID:31225646 |
|
NCBI chr 9:23,661,278...23,990,248
Ensembl chr 9:23,664,952...23,990,027
|
|
G
|
Smad1
|
SMAD family member 1
|
increases expression
|
ISO
|
azadirachtin results in increased expression of SMAD1 protein modified form
|
CTD |
PMID:31225646 |
|
NCBI chr19:28,513,130...28,573,665
Ensembl chr19:45,417,433...45,477,957
|
|
G
|
Tnf
|
tumor necrosis factor
|
decreases expression
|
ISO
|
azadirachtin results in decreased expression of TNF mRNA
|
CTD |
PMID:31225646 |
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
G
|
Tnfrsf11a
|
TNF receptor superfamily member 11A
|
multiple interactions decreases expression
|
ISO
|
azadirachtin inhibits the reaction [Estrogens deficiency results in increased expression of TNFRSF11A mRNA] azadirachtin results in decreased expression of TNFRSF11A mRNA
|
CTD |
PMID:31225646 |
|
NCBI chr13:22,442,930...22,501,257
Ensembl chr13:22,442,665...22,501,257
|
|
G
|
Tp53
|
tumor protein p53
|
increases expression
|
ISO
|
azadirachtin results in increased expression of TP53 mRNA; azadirachtin results in increased expression of TP53 protein
|
CTD |
PMID:20429769 |
|
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299
|
|
|
G
|
Acan
|
aggrecan
|
multiple interactions
|
EXP
|
bafilomycin A1 promotes the reaction [Corticosterone results in decreased expression of ACAN protein]
|
CTD |
PMID:38759937 |
|
NCBI chr 1:132,981,582...133,044,416
Ensembl chr 1:142,390,951...142,453,779
|
|
G
|
Agt
|
angiotensinogen
|
multiple interactions
|
EXP
|
bafilomycin A1 inhibits the reaction [AGT protein affects the localization of Calcium]
|
CTD |
PMID:21613610 |
|
NCBI chr19:69,426,540...69,447,017
Ensembl chr19:69,421,638...69,446,944
|
|
G
|
Aim2
|
absent in melanoma 2
|
multiple interactions
|
ISO
|
[bafilomycin A1 co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in increased expression of AIM2 protein
|
CTD |
PMID:32645460 |
|
NCBI chr13:85,865,206...85,906,996
Ensembl chr13:88,404,048...88,439,318
|
|
G
|
Akt1s1
|
AKT1 substrate 1
|
multiple interactions
|
EXP
|
bafilomycin A1 inhibits the reaction [EGF protein results in increased phosphorylation of AKT1S1 protein]; bafilomycin A1 inhibits the reaction [Lidocaine results in decreased expression of [MTOR protein binds to RPTOR protein binds to MLST8 protein binds to PRAS40 protein binds to DEPTOR protein]]
|
CTD |
PMID:22689575 PMID:37914286 |
|
NCBI chr 1:95,333,186...95,339,678
Ensembl chr 1:104,469,803...104,476,167
|
|
G
|
Alb
|
albumin
|
decreases uptake
|
ISO
|
bafilomycin A1 results in decreased uptake of ALB protein
|
CTD |
PMID:16313995 |
|
NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,891,582...17,911,865
|
|
G
|
Apaf1
|
apoptotic peptidase activating factor 1
|
increases expression
|
ISO
|
bafilomycin A1 results in increased expression of APAF1 protein
|
CTD |
PMID:28483490 |
|
NCBI chr 7:27,381,392...27,466,772
Ensembl chr 7:27,381,855...27,466,772
|
|
G
|
Appl1
|
adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1
|
multiple interactions
|
ISO
|
bafilomycin A1 promotes the reaction [Lipopolysaccharides results in increased degradation of APPL1 protein]; bafilomycin A1 promotes the reaction [Poly I-C results in increased degradation of APPL1 protein]
|
CTD |
PMID:25780039 |
|
NCBI chr16:2,125,234...2,173,457
Ensembl chr16:2,125,234...2,173,421
|
|
G
|
Arf6
|
ARF GTPase 6
|
multiple interactions
|
EXP
|
bafilomycin A1 inhibits the reaction [maduramicin results in decreased expression of ARF6 protein]
|
CTD |
PMID:37394175 |
|
NCBI chr 6:93,589,777...93,590,925
Ensembl chr 6:93,569,234...93,610,536
|
|
G
|
Asic1
|
acid sensing ion channel subunit 1
|
multiple interactions
|
ISO
|
bafilomycin A1 inhibits the reaction [Freund's Adjuvant results in increased expression of ASIC1 mRNA]
|
CTD |
PMID:16769263 |
|
NCBI chr 7:130,798,317...130,828,535
Ensembl chr 7:132,698,723...132,707,832
|
|
G
|
Atg5
|
autophagy related 5
|
multiple interactions
|
ISO
|
ATG5 protein affects the reaction [bafilomycin A1 promotes the reaction [gossypol acetic acid results in increased expression of MAP1LC3B protein modified form]] [bafilomycin A1 co-treated with Swainsonine] results in increased expression of ATG5 mRNA; [bafilomycin A1 co-treated with Swainsonine] results in increased lipidation of ATG5 protein
|
CTD |
PMID:29938581 PMID:36402259 |
|
NCBI chr20:49,380,835...49,471,826
Ensembl chr20:49,380,813...49,471,821
|
|
G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
multiple interactions
|
ISO
|
bafilomycin A1 inhibits the reaction [Hydroxychloroquine results in increased activity of BAX protein]
|
CTD |
PMID:12813466 |
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
|
|
G
|
Bcl2
|
BCL2, apoptosis regulator
|
decreases expression multiple interactions
|
ISO EXP
|
bafilomycin A1 results in decreased expression of BCL2 mRNA bafilomycin A1 promotes the reaction [Methamphetamine results in decreased expression of BCL2 protein]
|
CTD |
PMID:31310755 PMID:34374793 |
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
|
|
G
|
Becn1
|
beclin 1
|
multiple interactions increases expression
|
ISO EXP
|
bafilomycin A1 inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of BECN1 protein] [Swainsonine co-treated with bafilomycin A1] results in increased expression of BECN1 protein; bafilomycin A1 promotes the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of BECN1 protein] bafilomycin A1 results in increased expression of BECN1 protein
|
CTD |
PMID:32645460 PMID:33186601 PMID:33242459 |
|
NCBI chr10:86,731,649...86,747,002
Ensembl chr10:86,731,650...86,747,002
|
|
G
|
Bglap
|
bone gamma-carboxyglutamate protein
|
multiple interactions
|
ISO
|
bafilomycin A1 inhibits the reaction [[Dexamethasone co-treated with ascorbate-2-phosphate co-treated with beta-glycerophosphoric acid] results in increased expression of BGLAP mRNA]
|
CTD |
PMID:23111315 |
|
NCBI chr 2:176,136,341...176,137,318
Ensembl chr 2:176,136,341...176,137,318
|
|
G
|
Bid
|
BH3 interacting domain death agonist
|
multiple interactions increases cleavage increases expression
|
EXP ISO
|
bafilomycin A1 inhibits the reaction [manganese chloride results in increased expression of BID protein modified form]; bafilomycin A1 inhibits the reaction [manganese chloride results in increased expression of BID protein] vistusertib affects the reaction [bafilomycin A1 results in increased cleavage of BID protein] bafilomycin A1 results in increased expression of BID protein modified form
|
CTD |
PMID:26853465 PMID:28378122 |
|
NCBI chr 4:155,785,366...155,808,775
Ensembl chr 4:155,785,377...155,808,275
|
|
G
|
Bnip3
|
BCL2 interacting protein 3
|
increases expression multiple interactions
|
ISO
|
bafilomycin A1 results in increased expression of BNIP3 mRNA; bafilomycin A1 results in increased expression of BNIP3 protein BNIP3 mutant form promotes the reaction [bafilomycin A1 results in increased cleavage of PARP1 protein]; capivasertib affects the reaction [bafilomycin A1 results in increased expression of BNIP3 protein]; Erlotinib Hydrochloride inhibits the reaction [bafilomycin A1 results in increased expression of BNIP3 protein]; Gefitinib inhibits the reaction [bafilomycin A1 results in increased expression of BNIP3 protein]; HIF1A mutant form inhibits the reaction [bafilomycin A1 results in increased expression of BNIP3 mRNA]; Lapatinib inhibits the reaction [bafilomycin A1 results in increased expression of BNIP3 mRNA]; vistusertib inhibits the reaction [bafilomycin A1 results in increased expression of BNIP3 protein]
|
CTD |
PMID:25981168 PMID:26853465 |
|
NCBI chr 1:203,137,778...203,154,962
Ensembl chr 1:203,137,778...203,154,962
|
|
G
|
Casp3
|
caspase 3
|
decreases activity increases cleavage multiple interactions increases activity
|
ISO EXP
|
bafilomycin A1 results in decreased activity of CASP3 protein bafilomycin A1 results in increased cleavage of CASP3 protein bafilomycin A1 inhibits the reaction [Cadmium results in increased cleavage of CASP3 protein] bafilomycin A1 results in increased activity of CASP3 protein [Swainsonine co-treated with bafilomycin A1] results in increased cleavage of CASP3 protein; bafilomycin A1 inhibits the reaction [manganese chloride results in increased cleavage of CASP3 protein]; bafilomycin A1 promotes the reaction [Hydrogen Peroxide results in increased expression of CASP3 protein modified form]; bafilomycin A1 promotes the reaction [Methamphetamine results in increased cleavage of CASP3 protein] [bafilomycin A1 co-treated with Cannabidiol] results in increased cleavage of CASP3 protein; [bafilomycin A1 co-treated with cobaltous chloride co-treated with TP53 gene mutant form] results in increased activity of CASP3 protein; [bafilomycin A1 co-treated with methanandamide] results in increased cleavage of CASP3 protein; [Cannabidiol co-treated with bafilomycin A1] results in increased cleavage of CASP3 protein; bafilomycin A1 inhibits the reaction [Soot analog results in increased expression of CASP3 protein]; bafilomycin A1 inhibits the reaction [tetrandrine results in increased cleavage of CASP3 protein]; bafilomycin A1 promotes the reaction [Atorvastatin results in increased cleavage of CASP3 protein]; bafilomycin A1 promotes the reaction [brazilin results in increased activity of CASP3 protein]; bafilomycin A1 promotes the reaction [fosbretabulin results in increased cleavage of CASP3 protein]; tin protoporphyrin IX inhibits the reaction [[bafilomycin A1 co-treated with Cannabidiol] results in increased cleavage of CASP3 protein]; tin protoporphyrin IX inhibits the reaction [[bafilomycin A1 co-treated with methanandamide] results in increased cleavage of CASP3 protein]; vistusertib affects the reaction [bafilomycin A1 results in increased cleavage of CASP3 protein]
|
CTD |
PMID:20876807 PMID:23380477 PMID:24321340 PMID:24889822 PMID:25266202 PMID:25981168 PMID:26853465 PMID:28063998 PMID:28378122 PMID:29111403 PMID:30240709 PMID:32708634 PMID:33076330 PMID:33186601 PMID:34374793 More...
|
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
G
|
Casp4
|
caspase 4
|
increases activity
|
ISO
|
bafilomycin A1 results in increased activity of CASP4 protein
|
CTD |
PMID:20371669 |
|
NCBI chr 8:2,599,017...2,635,097
Ensembl chr 8:10,883,769...10,920,727
|
|
G
|
Casp7
|
caspase 7
|
increases activity decreases activity
|
ISO
|
bafilomycin A1 results in increased activity of CASP7 protein bafilomycin A1 results in decreased activity of CASP7 protein
|
CTD |
PMID:20371669 PMID:25981168 |
|
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:265,442,676...265,482,512
|
|
G
|
Casp8
|
caspase 8
|
multiple interactions
|
EXP ISO
|
bafilomycin A1 inhibits the reaction [manganese chloride results in increased cleavage of CASP8 protein] bafilomycin A1 inhibits the reaction [Cadmium results in increased cleavage of CASP8 protein]
|
CTD |
PMID:28378122 PMID:29111403 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:67,758,033...67,806,699
|
|
G
|
Casp9
|
caspase 9
|
multiple interactions
|
EXP ISO
|
bafilomycin A1 inhibits the reaction [manganese chloride results in increased cleavage of CASP9 protein] bafilomycin A1 inhibits the reaction [Soot analog results in increased expression of CASP9 protein]
|
CTD |
PMID:28378122 PMID:30240709 |
|
Ensembl chr 5:159,391,188...159,409,648
|
|
G
|
Ccnd1
|
cyclin D1
|
multiple interactions
|
ISO
|
bafilomycin A1 inhibits the reaction [Dexamethasone results in decreased expression of CCND1 protein]
|
CTD |
PMID:33359579 |
|
NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810
|
|
G
|
Cdc25c
|
cell division cycle 25C
|
multiple interactions
|
ISO
|
bafilomycin A1 inhibits the reaction [xanthatin results in decreased stability of CDC25C protein]
|
CTD |
PMID:29074359 |
|
NCBI chr18:26,335,156...26,356,199
Ensembl chr18:26,609,959...26,630,292
|
|
G
|
Cdh1
|
cadherin 1
|
multiple interactions
|
ISO
|
bafilomycin A1 inhibits the reaction [Capsaicin results in increased expression of CDH1 protein]
|
CTD |
PMID:36044967 |
|
NCBI chr19:51,402,178...51,471,572
Ensembl chr19:51,402,034...51,471,565
|
|
G
|
Cdh2
|
cadherin 2
|
multiple interactions
|
ISO
|
bafilomycin A1 inhibits the reaction [Capsaicin results in decreased expression of CDH2 protein]
|
CTD |
PMID:36044967 |
|
NCBI chr18:8,051,097...8,265,288
Ensembl chr18:8,051,097...8,265,288
|
|
G
|
Ctsb
|
cathepsin B
|
multiple interactions
|
ISO
|
bafilomycin A1 inhibits the reaction [[cobaltous chloride co-treated with TP53 gene mutant form] results in increased activity of CTSB protein]; bafilomycin A1 inhibits the reaction [Hydroxychloroquine affects the localization of CTSB protein]
|
CTD |
PMID:12813466 PMID:23380477 |
|
NCBI chr15:41,565,607...41,586,479
Ensembl chr15:41,565,611...41,586,478
|
|
G
|
Ctsd
|
cathepsin D
|
decreases cleavage
|
ISO
|
bafilomycin A1 results in decreased cleavage of CTSD protein
|
CTD |
PMID:36070022 |
|
NCBI chr 1:206,956,945...206,968,821
Ensembl chr 1:206,956,944...206,968,821
|
|
G
|
Ctsl
|
cathepsin L
|
decreases cleavage
|
ISO
|
bafilomycin A1 results in decreased cleavage of CTSL protein
|
CTD |
PMID:36070022 |
|
NCBI chr17:770,104...776,266
Ensembl chr17:770,093...777,113
|
|
G
|
Cxcl10
|
C-X-C motif chemokine ligand 10
|
multiple interactions
|
ISO
|
bafilomycin A1 inhibits the reaction [CpG ODN 2216 results in increased expression of CXCL10 protein]; bafilomycin A1 inhibits the reaction [gardiquimod results in increased expression of CXCL10 protein]; bafilomycin A1 inhibits the reaction [Poly I-C results in increased expression of CXCL10 protein]
|
CTD |
PMID:26682054 |
|
NCBI chr14:15,989,066...15,991,263
Ensembl chr14:15,989,018...15,991,261
|
|
G
|
Ddit4
|
DNA-damage-inducible transcript 4
|
increases expression multiple interactions
|
EXP
|
bafilomycin A1 results in increased expression of DDIT4 protein [EGF protein co-treated with bafilomycin A1] results in increased expression of DDIT4 protein
|
CTD |
PMID:22689575 |
|
NCBI chr20:27,891,989...27,894,088
Ensembl chr20:28,434,944...28,437,037
|
|
G
|
Deptor
|
DEP domain containing MTOR-interacting protein
|
multiple interactions
|
EXP
|
bafilomycin A1 inhibits the reaction [Lidocaine results in decreased expression of [MTOR protein binds to RPTOR protein binds to MLST8 protein binds to PRAS40 protein binds to DEPTOR protein]]
|
CTD |
PMID:37914286 |
|
NCBI chr 7:88,404,745...88,574,065
Ensembl chr 7:88,404,620...88,574,041
|
|
G
|
Egf
|
epidermal growth factor
|
multiple interactions
|
EXP
|
[bafilomycin A1 co-treated with EGF protein] results in decreased abundance of Arginine; [bafilomycin A1 co-treated with EGF protein] results in decreased abundance of Asparagine; [bafilomycin A1 co-treated with EGF protein] results in decreased abundance of Isoleucine; [bafilomycin A1 co-treated with EGF protein] results in decreased abundance of Leucine; [bafilomycin A1 co-treated with EGF protein] results in decreased abundance of Lysine; [bafilomycin A1 co-treated with EGF protein] results in decreased abundance of Methionine; [bafilomycin A1 co-treated with EGF protein] results in decreased abundance of Ornithine; [bafilomycin A1 co-treated with EGF protein] results in decreased abundance of Phenylalanine; [bafilomycin A1 co-treated with EGF protein] results in decreased abundance of Tyrosine; [bafilomycin A1 co-treated with EGF protein] results in decreased abundance of Valine; [bafilomycin A1 co-treated with EGF protein] results in increased abundance of Aspartic Acid; [bafilomycin A1 co-treated with EGF protein] results in increased abundance of Taurine; [EGF protein co-treated with bafilomycin A1] results in increased expression of DDIT4 protein; bafilomycin A1 inhibits the reaction [EGF protein results in increased activity of and results in increased phosphorylation of RPS6KB1 protein]; bafilomycin A1 inhibits the reaction [EGF protein results in increased phosphorylation of AKT1S1 protein]; bafilomycin A1 inhibits the reaction [EGF protein results in increased phosphorylation of EIF4EBP1 protein]; Cycloheximide inhibits the reaction [[bafilomycin A1 co-treated with EGF protein] results in decreased abundance of Arginine]; Cycloheximide inhibits the reaction [[bafilomycin A1 co-treated with EGF protein] results in decreased abundance of Asparagine]; Cycloheximide inhibits the reaction [[bafilomycin A1 co-treated with EGF protein] results in decreased abundance of Isoleucine]; Cycloheximide inhibits the reaction [[bafilomycin A1 co-treated with EGF protein] results in decreased abundance of Leucine]; Cycloheximide inhibits the reaction [[bafilomycin A1 co-treated with EGF protein] results in decreased abundance of Lysine]; Cycloheximide inhibits the reaction [[bafilomycin A1 co-treated with EGF protein] results in decreased abundance of Methionine]; Cycloheximide inhibits the reaction [[bafilomycin A1 co-treated with EGF protein] results in decreased abundance of Ornithine]; Cycloheximide inhibits the reaction [[bafilomycin A1 co-treated with EGF protein] results in decreased abundance of Phenylalanine]; Cycloheximide inhibits the reaction [[bafilomycin A1 co-treated with EGF protein] results in decreased abundance of Tyrosine]; Cycloheximide inhibits the reaction [[bafilomycin A1 co-treated with EGF protein] results in decreased abundance of Valine]
|
CTD |
PMID:22689575 |
|
NCBI chr 2:220,893,660...220,976,331
Ensembl chr 2:220,893,660...220,976,297
|
|
G
|
Egfr
|
epidermal growth factor receptor
|
multiple interactions
|
ISO
|
bafilomycin A1 inhibits the reaction [Arsenic Trioxide results in decreased expression of EGFR protein]
|
CTD |
PMID:30237564 |
|
NCBI chr14:95,378,626...95,551,358
Ensembl chr14:95,378,626...95,551,358
|
|
G
|
Eif4ebp1
|
eukaryotic translation initiation factor 4E binding protein 1
|
multiple interactions
|
EXP
|
bafilomycin A1 inhibits the reaction [EGF protein results in increased phosphorylation of EIF4EBP1 protein]; bafilomycin A1 inhibits the reaction [INS protein results in increased phosphorylation of EIF4EBP1 protein]
|
CTD |
PMID:22689575 |
|
NCBI chr16:71,495,457...71,508,845
Ensembl chr16:71,487,930...71,508,874
|
|
G
|
Epor
|
erythropoietin receptor
|
multiple interactions
|
ISO
|
bafilomycin A1 inhibits the reaction [Aristolochic Acids results in increased degradation of and results in decreased expression of EPOR protein]
|
CTD |
PMID:26136230 |
|
NCBI chr 8:28,765,738...28,770,371
Ensembl chr 8:28,765,746...28,770,322
|
|
G
|
Faslg
|
Fas ligand
|
multiple interactions
|
ISO EXP
|
bafilomycin A1 inhibits the reaction [FASL protein affects the localization of Calcium] bafilomycin A1 inhibits the reaction [manganese chloride results in increased expression of FASLG protein]
|
CTD |
PMID:20200208 PMID:28378122 |
|
NCBI chr13:76,680,885...76,706,042
Ensembl chr13:76,688,243...76,695,503
|
|
G
|
Fmc1
|
formation of mitochondrial complex V assembly factor 1
|
multiple interactions
|
ISO
|
bafilomycin A1 inhibits the reaction [Carbonyl Cyanide m-Chlorophenyl Hydrazone results in decreased expression of FMC1 protein]
|
CTD |
PMID:29371327 |
|
NCBI chr 4:67,274,104...67,282,140
Ensembl chr 4:68,241,009...68,268,534
|
|
G
|
Foxo1
|
forkhead box O1
|
multiple interactions
|
EXP
|
bafilomycin A1 inhibits the reaction [resveratrol inhibits the reaction [Hydrogen Peroxide results in increased acetylation of FOXO1 protein]]
|
CTD |
PMID:24889822 |
|
NCBI chr 2:138,462,974...138,541,420
Ensembl chr 2:138,462,697...138,541,419
|
|
G
|
Fth1
|
ferritin heavy chain 1
|
multiple interactions
|
ISO
|
bafilomycin A1 affects the reaction [[PRKD2 protein affects the susceptibility to erastin] which affects the expression of FTH1 protein]
|
CTD |
PMID:37951334 |
|
NCBI chr 1:216,052,037...216,054,325
Ensembl chr 1:216,051,998...216,055,214
|
|
G
|
Ftl1
|
ferritin light chain 1
|
multiple interactions
|
ISO
|
bafilomycin A1 affects the reaction [[PRKD2 protein affects the susceptibility to erastin] which affects the expression of FTL protein]
|
CTD |
PMID:37951334 |
|
NCBI chr 1:95,936,387...95,938,234
Ensembl chr X:45,399,355...45,399,915 Ensembl chr 2:45,399,355...45,399,915 Ensembl chr 1:45,399,355...45,399,915
|
|
G
|
Gja1
|
gap junction protein, alpha 1
|
increases expression
|
ISO
|
bafilomycin A1 results in increased expression of GJA1 protein
|
CTD |
PMID:35750204 |
|
NCBI chr20:36,302,490...36,315,010
Ensembl chr20:36,302,352...36,319,689
|
|
G
|
Hif1a
|
hypoxia inducible factor 1 subunit alpha
|
increases expression multiple interactions
|
ISO
|
bafilomycin A1 results in increased expression of HIF1A protein HIF1A mutant form inhibits the reaction [bafilomycin A1 results in increased expression of BNIP3 mRNA]; HIF1A mutant form promotes the reaction [bafilomycin A1 results in increased cleavage of PARP1 protein]; lapatinib inhibits the reaction [bafilomycin A1 results in increased expression of HIF1A protein]
|
CTD |
PMID:25981168 |
|
NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:98,359,910...98,405,323
|
|
G
|
Hmox1
|
heme oxygenase 1
|
decreases expression multiple interactions
|
ISO
|
bafilomycin A1 results in decreased expression of HMOX1 protein [bafilomycin A1 co-treated with methanandamide] results in increased expression of HMOX1 protein; [bafilomycin A1 co-treated with tin protoporphyrin IX] promotes the reaction [Cannabidiol results in increased expression of HMOX1 protein]; bafilomycin A1 inhibits the reaction [4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole results in increased expression of HMOX1 protein]
|
CTD |
PMID:29796178 PMID:33076330 |
|
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
|
|
G
|
Ifng
|
interferon gamma
|
decreases expression
|
ISO
|
bafilomycin A1 results in decreased expression of IFNG mRNA
|
CTD |
PMID:16932910 |
|
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:55,761,736...55,793,216
|
|
G
|
Il1b
|
interleukin 1 beta
|
decreases expression multiple interactions
|
ISO
|
bafilomycin A1 results in decreased expression of IL1B mRNA [bafilomycin A1 co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in increased expression of IL1B protein; bafilomycin A1 inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with aluminum sulfate] results in increased secretion of IL1B protein]
|
CTD |
PMID:16932910 PMID:24158569 PMID:32645460 |
|
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
|
|
G
|
Il6
|
interleukin 6
|
increases expression
|
ISO
|
bafilomycin A1 results in increased expression of IL6 mRNA
|
CTD |
PMID:16932910 |
|
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
|
|
G
|
Ins1
|
insulin 1
|
multiple interactions
|
ISO
|
bafilomycin A1 promotes the reaction [Palmitic Acid inhibits the reaction [INS1 protein results in increased uptake of 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose]]
|
CTD |
PMID:32283200 |
|
NCBI chr 1:261,186,119...261,186,686
Ensembl chr 1:261,186,119...261,186,682
|
|
G
|
Ins2
|
insulin 2
|
multiple interactions
|
EXP
|
bafilomycin A1 inhibits the reaction [INS protein results in increased phosphorylation of EIF4EBP1 protein]; bafilomycin A1 inhibits the reaction [INS protein results in increased phosphorylation of RPS6KB1 protein]
|
CTD |
PMID:22689575 |
|
NCBI chr 1:207,272,738...207,421,998
Ensembl chr 1:207,272,742...207,273,805
|
|
G
|
Keap1
|
Kelch-like ECH-associated protein 1
|
multiple interactions
|
ISO
|
bafilomycin A1 promotes the reaction [pachastrissamine analog promotes the reaction [KEAP1 protein binds to SQSTM1 protein]]
|
CTD |
PMID:35123989 |
|
NCBI chr 8:28,044,555...28,054,042
Ensembl chr 8:28,044,555...28,054,042
|
|
G
|
Lamp1
|
lysosomal-associated membrane protein 1
|
multiple interactions increases expression
|
ISO
|
[bafilomycin A1 co-treated with Swainsonine] results in increased expression of LAMP1 mRNA; [bafilomycin A1 co-treated with Swainsonine] results in increased expression of LAMP1 protein bafilomycin A1 results in increased expression of LAMP1 protein
|
CTD |
PMID:36402259 |
|
NCBI chr16:83,058,131...83,082,843
Ensembl chr16:83,058,385...83,075,159
|
|
G
|
Lcat
|
lecithin cholesterol acyltransferase
|
multiple interactions
|
EXP
|
bafilomycin A1 promotes the reaction [C1QTNF9 protein results in increased expression of MAP1LC3B protein modified form]
|
CTD |
PMID:32278738 |
|
NCBI chr19:33,834,748...33,838,214
Ensembl chr19:50,744,601...50,748,081
|
|
G
|
Lrrk2
|
leucine-rich repeat kinase 2
|
increases response to substance
|
ISO
|
LRRK2 gene mutant form results in increased susceptibility to bafilomycin A1
|
CTD |
PMID:25017139 |
|
NCBI chr 7:124,706,246...124,867,234
Ensembl chr 7:124,706,080...124,867,239
|
|
G
|
Man2a1
|
mannosidase, alpha, class 2A, member 1
|
multiple interactions
|
ISO
|
bafilomycin A1 inhibits the reaction [Swainsonine results in decreased expression of MAN2A1 mRNA]
|
CTD |
PMID:36402259 |
|
NCBI chr 9:104,252,001...104,408,349
Ensembl chr 9:111,698,913...111,867,850
|
|
G
|
Man2b1
|
mannosidase, alpha, class 2B, member 1
|
multiple interactions
|
ISO
|
bafilomycin A1 inhibits the reaction [Swainsonine results in decreased expression of MAN2B1 mRNA]
|
CTD |
PMID:36402259 |
|
NCBI chr19:23,055,092...23,074,398
Ensembl chr19:39,959,965...39,979,246
|
|
G
|
Map1lc3a
|
microtubule-associated protein 1 light chain 3 alpha
|
multiple interactions increases expression
|
ISO EXP
|
bafilomycin A1 promotes the reaction [Uranium results in increased expression of MAP1LC3A protein] bafilomycin A1 inhibits the reaction [Lidocaine results in increased expression of MAP1LC3A protein] bafilomycin A1 results in increased expression of MAP1LC3A protein modified form
|
CTD |
PMID:30871063 PMID:31120128 PMID:37914286 |
|
NCBI chr 3:164,243,204...164,244,850
Ensembl chr 3:164,243,093...164,244,850
|
|
G
|
Map1lc3b
|
microtubule-associated protein 1 light chain 3 beta
|
multiple interactions increases lipidation increases expression increases cleavage decreases degradation
|
ISO EXP
|
[bafilomycin A1 co-treated with Miconazole] results in increased expression of MAP1LC3B protein; [di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone co-treated with bafilomycin A1] results in increased expression of MAP1LC3B mRNA; [TNF protein co-treated with bafilomycin A1] results in increased expression of MAP1LC3B protein alternative form; Acetylcysteine inhibits the reaction [di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone promotes the reaction [bafilomycin A1 results in increased expression of MAP1LC3B protein]]; ATG5 protein affects the reaction [bafilomycin A1 promotes the reaction [gossypol acetic acid results in increased expression of MAP1LC3B protein modified form]]; bafilomycin A1 affects the reaction [Ammonium Chloride results in increased metabolism of MAP1LC3B protein]; bafilomycin A1 affects the reaction [AZD4547 affects the expression of MAP1LC3B protein modified form]; bafilomycin A1 affects the reaction [AZD8186 affects the expression of MAP1LC3B protein modified form]; bafilomycin A1 inhibits the reaction [Chloroquine results in increased lipidation of MAP1LC3B protein]; bafilomycin A1 promotes the reaction [[alpha-Chlorohydrin co-treated with Diosgenin] results in increased lipidation of MAP1LC3B protein]; bafilomycin A1 promotes the reaction [capivasertib results in increased expression of MAP1LC3B protein modified form]; bafilomycin A1 promotes the reaction [Curcumin results in increased lipidation of MAP1LC3B protein]; bafilomycin A1 promotes the reaction [ginsenoside Rg2 results in increased expression of MAP1LC3B protein modified form]; bafilomycin A1 promotes the reaction [gossypol acetic acid results in increased expression of MAP1LC3B protein modified form]; bafilomycin A1 promotes the reaction [metarrestin results in increased expression of MAP1LC3B protein modified form]; bafilomycin A1 promotes the reaction [Miconazole results in increased lipidation of MAP1LC3B protein]; bafilomycin A1 promotes the reaction [ovatodiolide results in increased lipidation of MAP1LC3B protein]; bafilomycin A1 promotes the reaction [Particulate Matter results in increased expression of MAP1LC3B protein]; bafilomycin A1 promotes the reaction [Resveratrol results in increased expression of MAP1LC3B protein alternative form]; bafilomycin A1 promotes the reaction [Sevoflurane results in increased lipidation of MAP1LC3B protein]; bafilomycin A1 promotes the reaction [vistusertib results in increased expression of MAP1LC3B protein modified form]; bafilomycin A1 results in increased expression of and results in increased lipidation of MAP1LC3B protein; di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone promotes the reaction [bafilomycin A1 results in increased expression of MAP1LC3B protein]; Resveratrol promotes the reaction [[TNF protein co-treated with bafilomycin A1] results in increased expression of MAP1LC3B protein alternative form] bafilomycin A1 results in increased lipidation of MAP1LC3B protein [Doxorubicin co-treated with bafilomycin A1] results in increased expression of MAP1LC3B protein; [Glycyrrhizic Acid co-treated with bafilomycin A1] results in increased lipidation of MAP1LC3B protein; bafilomycin A1 inhibits the reaction [olaparib inhibits the reaction [Hydrogen Peroxide results in increased lipidation of MAP1LC3B protein]]; bafilomycin A1 promotes the reaction [C1QTNF9 protein results in increased expression of MAP1LC3B protein modified form]; bafilomycin A1 promotes the reaction [Corticosterone results in increased lipidation of MAP1LC3B protein] bafilomycin A1 results in increased expression of MAP1LC3B protein modified form [bafilomycin A1 co-treated with Swainsonine] results in increased expression of MAP1LC3B mRNA; [bafilomycin A1 co-treated with Swainsonine] results in increased lipidation of MAP1LC3B protein; bafilomycin A1 promotes the reaction [tricalcium phosphate results in increased expression of MAP1LC3B protein]; bafilomycin A1 promotes the reaction [Triiodothyronine results in increased lipidation of MAP1LC3B protein]; Triiodothyronine promotes the reaction [bafilomycin A1 results in increased lipidation of MAP1LC3B protein] bafilomycin A1 results in increased cleavage of MAP1LC3B protein bafilomycin A1 results in decreased degradation of MAP1LC3B protein modified form bafilomycin A1 results in increased expression of MAP1LC3B protein; bafilomycin A1 results in increased expression of MAP1LC3B protein alternative form; bafilomycin A1 results in increased expression of MAP1LC3B protein modified form
|
CTD |
PMID:23880069 PMID:24145604 PMID:25301941 PMID:26459185 PMID:26853465 PMID:27305347 PMID:29248574 PMID:29524503 PMID:29908302 PMID:29938581 PMID:30209975 PMID:31310755 PMID:32278738 PMID:32525084 PMID:32981224 PMID:33124469 PMID:34580807 PMID:34634291 PMID:35149085 PMID:35472370 PMID:35872226 PMID:36070022 PMID:36402259 PMID:36639873 PMID:37678662 PMID:38000454 PMID:38759937 More...
|
|
NCBI chr19:66,571,631...66,582,270
Ensembl chr19:66,574,407...66,584,358 Ensembl chr16:66,574,407...66,584,358
|
|
G
|
Mapk1
|
mitogen activated protein kinase 1
|
multiple interactions increases expression
|
ISO
|
bafilomycin A1 inhibits the reaction [Capsaicin results in increased activity of MAPK1 protein]; bafilomycin A1 inhibits the reaction [Iron Compounds results in increased expression of MAPK1 protein modified form]; bafilomycin A1 promotes the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased phosphorylation of MAPK1 protein] bafilomycin A1 results in increased expression of MAPK1 protein modified form
|
CTD |
PMID:20371669 PMID:28483490 PMID:32645460 |
|
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825
|
|
G
|
Mapk3
|
mitogen activated protein kinase 3
|
multiple interactions increases expression
|
ISO
|
bafilomycin A1 inhibits the reaction [Capsaicin results in increased activity of MAPK3 protein]; bafilomycin A1 inhibits the reaction [Iron Compounds results in increased expression of MAPK3 protein modified form]; bafilomycin A1 promotes the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased phosphorylation of MAPK3 protein] bafilomycin A1 results in increased expression of MAPK3 protein modified form
|
CTD |
PMID:20371669 PMID:28483490 PMID:32645460 |
|
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411
|
|
G
|
Mapk8
|
mitogen-activated protein kinase 8
|
increases phosphorylation
|
ISO
|
bafilomycin A1 results in increased phosphorylation of MAPK8 protein
|
CTD |
PMID:31310755 |
|
NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,645,198...8,728,427
|
|
G
|
Mlst8
|
MTOR associated protein, LST8 homolog
|
multiple interactions
|
EXP
|
bafilomycin A1 inhibits the reaction [Lidocaine results in decreased expression of [MTOR protein binds to RPTOR protein binds to MLST8 protein binds to PRAS40 protein binds to DEPTOR protein]]
|
CTD |
PMID:37914286 |
|
NCBI chr10:14,002,927...14,008,678
Ensembl chr10:14,002,938...14,008,678
|
|
G
|
Mtor
|
mechanistic target of rapamycin kinase
|
decreases phosphorylation multiple interactions
|
ISO EXP
|
bafilomycin A1 results in decreased phosphorylation of MTOR protein bafilomycin A1 inhibits the reaction [Lidocaine results in decreased expression of [MTOR protein binds to RPTOR protein binds to MLST8 protein binds to PRAS40 protein binds to DEPTOR protein]]
|
CTD |
PMID:31310755 PMID:37914286 |
|
NCBI chr 5:164,167,985...164,277,438
Ensembl chr 5:164,167,928...164,277,435
|
|
G
|
Mttp
|
microsomal triglyceride transfer protein
|
increases expression
|
ISO
|
bafilomycin A1 results in increased expression of MTTP protein
|
CTD |
PMID:34516972 |
|
NCBI chr 2:229,286,501...229,327,650
Ensembl chr 2:229,286,501...229,327,650
|
|
G
|
Ncoa4
|
nuclear receptor coactivator 4
|
multiple interactions
|
ISO
|
bafilomycin A1 affects the reaction [[PRKD2 protein affects the susceptibility to erastin] which affects the expression of NCOA4 protein]
|
CTD |
PMID:37951334 |
|
NCBI chr16:7,389,222...7,409,564
Ensembl chr16:7,401,802...7,415,840
|
|
G
|
Ndrg1
|
N-myc downstream regulated 1
|
multiple interactions
|
ISO
|
NDRG1 protein results in decreased susceptibility to [di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone co-treated with bafilomycin A1]
|
CTD |
PMID:24532803 |
|
NCBI chr 7:100,573,526...100,614,902
Ensembl chr 7:100,573,523...100,614,913
|
|
G
|
Nfe2l2
|
NFE2 like bZIP transcription factor 2
|
multiple interactions increases expression
|
ISO
|
bafilomycin A1 promotes the reaction [[Particulate Matter co-treated with Vitamin D] results in increased expression of NFE2L2 protein]; bafilomycin A1 promotes the reaction [[Silicon Dioxide co-treated with Vitamin D] results in increased expression of NFE2L2 protein]; bafilomycin A1 promotes the reaction [Particulate Matter results in increased expression of NFE2L2 protein]; bafilomycin A1 promotes the reaction [Silicon Dioxide results in increased expression of NFE2L2 protein] bafilomycin A1 results in increased expression of NFE2L2 protein
|
CTD |
PMID:30698894 |
|
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090
|
|
G
|
Nlrp3
|
NLR family, pyrin domain containing 3
|
multiple interactions increases expression
|
ISO
|
bafilomycin A1 inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of NLRP3 protein] bafilomycin A1 results in increased expression of NLRP3 protein
|
CTD |
PMID:32645460 |
|
NCBI chr10:44,826,299...44,853,373
Ensembl chr10:44,828,014...44,853,394
|
|
G
|
Nr5a1
|
nuclear receptor subfamily 5, group A, member 1
|
decreases expression
|
ISO
|
bafilomycin A1 results in decreased expression of NR5A1 protein
|
CTD |
PMID:29524503 |
|
NCBI chr 3:22,464,786...22,486,328
Ensembl chr 3:42,875,221...42,896,046
|
|
G
|
Parp1
|
poly (ADP-ribose) polymerase 1
|
multiple interactions increases cleavage increases expression
|
ISO EXP
|
[Cysteine Proteinase Inhibitors results in decreased activity of USP8 protein] promotes the reaction [bafilomycin A1 results in increased cleavage of PARP1 protein]; bafilomycin A1 promotes the reaction [[Cysteine Proteinase Inhibitors results in decreased activity of USP8 protein] which results in increased cleavage of PARP1 protein]; bafilomycin A1 promotes the reaction [Atorvastatin results in increased cleavage of PARP1 protein]; bafilomycin A1 promotes the reaction [brazilin results in increased expression of PARP1 protein modified form]; bafilomycin A1 promotes the reaction [Flavanones results in increased cleavage of PARP1 protein]; bafilomycin A1 promotes the reaction [fosbretabulin results in increased cleavage of PARP1 protein]; BNIP3 mutant form promotes the reaction [bafilomycin A1 results in increased cleavage of PARP1 protein]; HIF1A mutant form promotes the reaction [bafilomycin A1 results in increased cleavage of PARP1 protein] bafilomycin A1 promotes the reaction [Methamphetamine results in increased cleavage of PARP1 protein] bafilomycin A1 inhibits the reaction [Cadmium results in increased cleavage of PARP1 protein] bafilomycin A1 results in increased expression of PARP1 protein modified form
|
CTD |
PMID:20876807 PMID:21616090 PMID:24321340 PMID:25981168 PMID:28063998 PMID:29111403 PMID:31310755 PMID:34374793 PMID:35022897 More...
|
|
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:94,839,433...94,871,567
|
|
G
|
Pcna
|
proliferating cell nuclear antigen
|
multiple interactions
|
ISO
|
bafilomycin A1 inhibits the reaction [Dexamethasone results in decreased expression of PCNA mRNA]
|
CTD |
PMID:33359579 |
|
NCBI chr 3:139,951,948...139,955,820
Ensembl chr 3:139,951,941...139,955,901
|
|
G
|
Pink1
|
PTEN induced kinase 1
|
multiple interactions
|
EXP
|
bafilomycin A1 inhibits the reaction [Lidocaine results in increased expression of PINK1 protein]
|
CTD |
PMID:37914286 |
|
NCBI chr 5:155,813,838...155,825,950
Ensembl chr 5:155,813,838...155,825,950
|
|
G
|
Prkaa1
|
protein kinase AMP-activated catalytic subunit alpha 1
|
multiple interactions
|
ISO EXP
|
bafilomycin A1 inhibits the reaction [2-chloroethyl ethyl sulfide results in decreased expression of PRKAA1 protein] bafilomycin A1 inhibits the reaction [Lidocaine results in increased phosphorylation of PRKAA1 protein]
|
CTD |
PMID:37481222 PMID:37914286 |
|
NCBI chr 2:55,967,766...56,003,450
Ensembl chr 2:55,967,351...56,003,450
|
|
G
|
Prkaa2
|
protein kinase AMP-activated catalytic subunit alpha 2
|
multiple interactions
|
ISO
|
bafilomycin A1 inhibits the reaction [2-chloroethyl ethyl sulfide results in decreased expression of PRKAA2 protein]
|
CTD |
PMID:37481222 |
|
NCBI chr 5:125,036,945...125,109,010
Ensembl chr 5:125,042,179...125,108,324
|
|
G
|
Prkd2
|
protein kinase D2
|
multiple interactions
|
ISO
|
[PRKD2 protein affects the susceptibility to [erastin co-treated with bafilomycin A1]] which affects the abundance of Malondialdehyde; bafilomycin A1 affects the reaction [[PRKD2 protein affects the susceptibility to erastin] which affects the expression of FTH1 protein]; bafilomycin A1 affects the reaction [[PRKD2 protein affects the susceptibility to erastin] which affects the expression of FTL protein]; bafilomycin A1 affects the reaction [[PRKD2 protein affects the susceptibility to erastin] which affects the expression of NCOA4 protein]; PRKD2 protein affects the susceptibility to [erastin co-treated with bafilomycin A1]
|
CTD |
PMID:37951334 |
|
NCBI chr 1:86,640,095...86,670,476
Ensembl chr 1:86,642,629...86,670,675
|
|
G
|
Rela
|
RELA proto-oncogene, NF-kB subunit
|
multiple interactions
|
ISO
|
bafilomycin A1 affects the localization of and results in increased activity of RELA protein
|
CTD |
PMID:10339586 |
|
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817
|
|
G
|
Rps6kb1
|
ribosomal protein S6 kinase B1
|
decreases phosphorylation multiple interactions
|
ISO EXP
|
bafilomycin A1 results in decreased phosphorylation of RPS6KB1 protein bafilomycin A1 inhibits the reaction [EGF protein results in increased activity of and results in increased phosphorylation of RPS6KB1 protein]; bafilomycin A1 inhibits the reaction [INS protein results in increased phosphorylation of RPS6KB1 protein]
|
CTD |
PMID:22689575 PMID:31310755 |
|
NCBI chr10:71,817,794...71,865,211
Ensembl chr10:71,815,614...71,865,238
|
|
G
|
Rptor
|
regulatory associated protein of MTOR, complex 1
|
multiple interactions
|
EXP
|
bafilomycin A1 inhibits the reaction [Lidocaine results in decreased expression of [MTOR protein binds to RPTOR protein binds to MLST8 protein binds to PRAS40 protein binds to DEPTOR protein]]
|
CTD |
PMID:37914286 |
|
NCBI chr10:104,878,487...105,176,986
Ensembl chr10:105,376,943...105,675,413
|
|
G
|
Runx2
|
RUNX family transcription factor 2
|
multiple interactions
|
ISO
|
bafilomycin A1 inhibits the reaction [[Dexamethasone co-treated with ascorbate-2-phosphate co-treated with beta-glycerophosphoric acid] results in increased expression of RUNX2 mRNA]
|
CTD |
PMID:23111315 |
|
NCBI chr 9:23,661,278...23,990,248
Ensembl chr 9:23,664,952...23,990,027
|
|
G
|
Sirt1
|
sirtuin 1
|
multiple interactions
|
EXP
|
bafilomycin A1 inhibits the reaction [resveratrol inhibits the reaction [Hydrogen Peroxide results in decreased expression of SIRT1 protein]]
|
CTD |
PMID:24889822 |
|
NCBI chr20:25,305,953...25,328,000
Ensembl chr20:25,305,476...25,328,000
|
|
G
|
Slc17a7
|
solute carrier family 17 member 7
|
multiple interactions
|
EXP
|
bafilomycin A1 inhibits the reaction [SLC17A7 protein results in increased uptake of Excitatory Amino Acid Agents]; bafilomycin A1 inhibits the reaction [SLC17A7 protein results in increased uptake of Zinc]; bafilomycin A1 inhibits the reaction [SLC30A3 protein promotes the reaction [SLC17A7 protein results in increased uptake of Zinc]]
|
CTD |
PMID:15860731 |
|
NCBI chr 1:95,649,709...95,661,591
Ensembl chr 1:104,785,955...104,798,049
|
|
G
|
Slc30a3
|
solute carrier family 30 member 3
|
multiple interactions
|
EXP
|
bafilomycin A1 inhibits the reaction [SLC30A3 protein promotes the reaction [SLC17A7 protein results in increased uptake of Zinc]]
|
CTD |
PMID:15860731 |
|
NCBI chr 6:30,984,241...31,004,689
Ensembl chr 6:30,984,276...31,005,120
|
|
G
|
Snai1
|
snail family transcriptional repressor 1
|
multiple interactions increases expression
|
ISO
|
bafilomycin A1 promotes the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SNAI1 protein] bafilomycin A1 results in increased expression of SNAI1 protein
|
CTD |
PMID:32645460 |
|
NCBI chr 3:156,248,479...156,252,969
|
|
G
|
Snca
|
synuclein alpha
|
multiple interactions increases expression
|
ISO
|
[bafilomycin A1 co-treated with Rotenone] results in increased expression of SNCA protein bafilomycin A1 results in increased expression of SNCA protein
|
CTD |
PMID:26031332 |
|
NCBI chr 4:91,026,474...91,127,444
Ensembl chr 4:91,026,474...91,126,315
|
|
G
|
Sort1
|
sortilin 1
|
decreases expression
|
ISO
|
bafilomycin A1 results in decreased expression of SORT1 protein
|
CTD |
PMID:25805502 |
|
NCBI chr 2:195,924,033...196,002,354
Ensembl chr 2:198,612,148...198,690,481
|
|
G
|
Sqstm1
|
sequestosome 1
|
increases expression multiple interactions
|
ISO EXP
|
bafilomycin A1 results in increased expression of SQSTM1 protein bafilomycin A1 inhibits the reaction [Corticosterone results in decreased expression of SQSTM1 protein]; bafilomycin A1 promotes the reaction [Hydrogen Peroxide results in increased expression of SQSTM1 protein] [Resveratrol co-treated with bafilomycin A1] results in increased expression of SQSTM1 protein; [Silicon Dioxide co-treated with bafilomycin A1] results in increased expression of SQSTM1 protein; [Silicon Dioxide co-treated with Vitamin D co-treated with bafilomycin A1] results in increased expression of SQSTM1 protein; [TNF protein co-treated with bafilomycin A1] results in increased expression of SQSTM1 protein; [Vitamin D co-treated with bafilomycin A1] results in increased expression of SQSTM1 protein; bafilomycin A1 inhibits the reaction [2-chloroethyl ethyl sulfide results in decreased expression of SQSTM1 protein]; bafilomycin A1 inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SQSTM1 protein]; bafilomycin A1 inhibits the reaction [dactolisib results in decreased expression of SQSTM1 protein]; bafilomycin A1 inhibits the reaction [Dexamethasone results in decreased expression of SQSTM1 protein]; bafilomycin A1 inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of SQSTM1 protein]]; bafilomycin A1 inhibits the reaction [Resveratrol results in increased degradation of SQSTM1 protein]; bafilomycin A1 inhibits the reaction [Sorafenib results in decreased expression of SQSTM1 protein]; bafilomycin A1 promotes the reaction [ginsenoside Rg2 results in decreased expression of SQSTM1 protein]; bafilomycin A1 promotes the reaction [metarrestin results in decreased expression of SQSTM1 protein]; bafilomycin A1 promotes the reaction [Miconazole results in increased expression of SQSTM1 protein]; bafilomycin A1 promotes the reaction [N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of SQSTM1 protein]; bafilomycin A1 promotes the reaction [pachastrissamine analog promotes the reaction [KEAP1 protein binds to SQSTM1 protein]]; Fingolimod Hydrochloride affects the reaction [bafilomycin A1 results in increased expression of SQSTM1 protein]; sodium arsenite promotes the reaction [bafilomycin A1 results in increased expression of SQSTM1 protein] [bafilomycin A1 co-treated with Rotenone] results in increased expression of SQSTM1 protein; [bafilomycin A1 co-treated with Swainsonine] results in increased expression of SQSTM1 mRNA; [bafilomycin A1 co-treated with Swainsonine] results in increased lipidation of SQSTM1 protein; bafilomycin A1 inhibits the reaction [Resveratrol inhibits the reaction [Streptozocin results in increased expression of SQSTM1 protein]]; bafilomycin A1 inhibits the reaction [Sirolimus results in decreased expression of SQSTM1 protein]; decamethrin promotes the reaction [bafilomycin A1 results in increased expression of SQSTM1 protein]; Streptozocin promotes the reaction [bafilomycin A1 results in increased expression of SQSTM1 protein]
|
CTD |
PMID:21778691 PMID:21858812 PMID:23151917 PMID:24145604 PMID:24238063 PMID:24889822 PMID:25939952 PMID:25943029 PMID:26031332 PMID:27305347 PMID:28125038 PMID:29248574 PMID:29524503 PMID:30698894 PMID:32186374 PMID:32645460 PMID:32981224 PMID:33124469 PMID:33359579 PMID:34405320 PMID:34520793 PMID:34580807 PMID:35123989 PMID:36070022 PMID:36402259 PMID:37481222 PMID:38759937 More...
|
|
NCBI chr10:34,525,517...34,536,670
Ensembl chr10:35,026,598...35,037,750
|
|
G
|
Stk11
|
serine/threonine kinase 11
|
multiple interactions
|
ISO
|
bafilomycin A1 inhibits the reaction [2-chloroethyl ethyl sulfide results in decreased expression of STK11 protein]
|
CTD |
PMID:37481222 |
|
NCBI chr 7:10,225,204...10,241,965
Ensembl chr 7:10,225,204...10,241,965
|
|
G
|
Tbk1
|
TANK-binding kinase 1
|
multiple interactions
|
ISO
|
bafilomycin A1 promotes the reaction [Lipopolysaccharides results in increased phosphorylation of TBK1 protein]; bafilomycin A1 promotes the reaction [Poly I-C results in increased phosphorylation of TBK1 protein]
|
CTD |
PMID:25780039 |
|
NCBI chr 7:57,077,830...57,110,868
Ensembl chr 7:58,963,325...58,996,357
|
|
G
|
Tlr8
|
toll-like receptor 8
|
multiple interactions
|
ISO
|
bafilomycin A1 inhibits the reaction [resiquimod results in increased activity of TLR8 protein]
|
CTD |
PMID:21398612 |
|
NCBI chr X:27,091,780...27,116,092
Ensembl chr X:30,708,033...30,737,079
|
|
G
|
Tnf
|
tumor necrosis factor
|
increases expression multiple interactions
|
ISO
|
bafilomycin A1 results in increased expression of TNF mRNA [TNF protein co-treated with bafilomycin A1] results in increased expression of MAP1LC3B protein alternative form; [TNF protein co-treated with bafilomycin A1] results in increased expression of SQSTM1 protein; resveratrol promotes the reaction [[TNF protein co-treated with bafilomycin A1] results in increased expression of MAP1LC3B protein alternative form]
|
CTD |
PMID:16932910 PMID:24145604 |
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
G
|
Tomm20
|
translocase of outer mitochondrial membrane 20
|
increases expression multiple interactions
|
ISO
|
bafilomycin A1 results in increased expression of TOMM20 protein Triiodothyronine promotes the reaction [bafilomycin A1 results in increased expression of TOMM20 protein]
|
CTD |
PMID:30209975 |
|
NCBI chr19:71,822,429...71,832,420
Ensembl chr19:71,822,411...71,832,510
|
|
G
|
Tp53
|
tumor protein p53
|
multiple interactions
|
ISO
|
[bafilomycin A1 co-treated with cobaltous chloride co-treated with TP53 gene mutant form] results in increased activity of CASP3 protein; bafilomycin A1 inhibits the reaction [[cobaltous chloride co-treated with TP53 gene mutant form] results in increased activity of CTSB protein]
|
CTD |
PMID:23380477 |
|
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299
|
|
G
|
Ulk1
|
unc-51 like autophagy activating kinase 1
|
multiple interactions
|
EXP
|
bafilomycin A1 affects the reaction [N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide affects the reaction [Glucose affects the phosphorylation of ULK1 protein]]
|
CTD |
PMID:29128638 |
|
NCBI chr12:51,511,492...51,537,746
Ensembl chr12:51,511,492...51,537,746
|
|
G
|
Usp8
|
ubiquitin specific peptidase 8
|
multiple interactions
|
ISO
|
[Cysteine Proteinase Inhibitors results in decreased activity of USP8 protein] promotes the reaction [bafilomycin A1 results in increased cleavage of PARP1 protein]; bafilomycin A1 promotes the reaction [[Cysteine Proteinase Inhibitors results in decreased activity of USP8 protein] which results in increased cleavage of PARP1 protein]
|
CTD |
PMID:35022897 |
|
NCBI chr 3:113,962,136...114,009,683
Ensembl chr 3:134,415,391...134,463,032
|
|
G
|
Vdac1
|
voltage-dependent anion channel 1
|
multiple interactions increases expression
|
ISO
|
Triiodothyronine promotes the reaction [bafilomycin A1 results in increased expression of VDAC1 protein]
|
CTD |
PMID:30209975 |
|
NCBI chr10:36,532,306...36,559,642
Ensembl chr10:37,023,145...37,060,541
|
|
G
|
Vdr
|
vitamin D receptor
|
multiple interactions
|
ISO
|
[bafilomycin A1 co-treated with Vitamin D] results in increased expression of VDR protein; [Silicon Dioxide co-treated with Vitamin D co-treated with bafilomycin A1] results in increased expression of VDR protein
|
CTD |
PMID:30698894 |
|
NCBI chr 7:130,864,764...130,916,757
Ensembl chr 7:130,866,745...130,916,757
|
|
G
|
Vim
|
vimentin
|
multiple interactions increases expression
|
ISO
|
bafilomycin A1 promotes the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of VIM protein] bafilomycin A1 results in increased expression of VIM protein
|
CTD |
PMID:32645460 |
|
NCBI chr17:81,577,261...81,585,746
Ensembl chr17:81,568,272...81,585,746
|
|
|
G
|
Birc3
|
baculoviral IAP repeat-containing 3
|
increases expression
|
ISO
|
bryostatin 1 results in increased expression of BIRC3 mRNA
|
CTD |
PMID:14527959 |
|
NCBI chr 8:13,285,702...13,313,329
Ensembl chr 8:13,285,703...13,298,590
|
|
G
|
Cd22
|
CD22 molecule
|
increases expression
|
ISO
|
bryostatin 1 results in increased expression of CD22 protein
|
CTD |
PMID:10741703 |
|
NCBI chr 1:95,243,785...95,270,430
Ensembl chr 1:95,244,868...95,259,730
|
|
G
|
Cdk1
|
cyclin-dependent kinase 1
|
multiple interactions
|
ISO
|
bryostatin 1 inhibits the reaction [Paclitaxel results in increased activity of CDK1 protein]
|
CTD |
PMID:10516758 |
|
NCBI chr20:19,265,252...19,280,456
Ensembl chr20:19,265,289...19,280,455
|
|
G
|
F3
|
coagulation factor III, tissue factor
|
increases expression
|
ISO
|
bryostatin 1 results in increased expression of F3 protein
|
CTD |
PMID:25569083 |
|
NCBI chr 2:212,511,675...212,523,375
Ensembl chr 2:212,511,680...212,523,369
|
|
G
|
Il10
|
interleukin 10
|
decreases expression
|
ISO
|
bryostatin 1 analog results in decreased expression of IL10 mRNA; bryostatin 1 results in decreased expression of IL10 mRNA
|
CTD |
PMID:15614042 |
|
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:45,025,087...45,029,580
|
|
G
|
Il12b
|
interleukin 12B
|
decreases expression increases expression
|
ISO
|
bryostatin 1 analog results in decreased expression of IL12B mRNA bryostatin 1 results in increased expression of IL12B mRNA
|
CTD |
PMID:15614042 |
|
NCBI chr10:29,390,300...29,405,194
Ensembl chr10:29,389,905...29,405,194
|
|
G
|
Itgax
|
integrin subunit alpha X
|
increases expression
|
ISO
|
bryostatin 1 results in increased expression of ITGAX protein
|
CTD |
PMID:10741703 |
|
NCBI chr 1:182,709,653...182,740,709
Ensembl chr 1:192,149,905...192,171,151
|
|
G
|
Prkca
|
protein kinase C, alpha
|
multiple interactions decreases expression
|
ISO
|
[bryostatin 1 co-treated with mezerein] results in decreased expression of PRKCA protein bryostatin 1 results in decreased expression of PRKCA protein
|
CTD |
PMID:8892972 |
|
NCBI chr10:93,388,991...93,787,617
Ensembl chr10:93,388,991...93,787,572
|
|
G
|
Prkcb
|
protein kinase C, beta
|
multiple interactions decreases expression
|
ISO
|
[bryostatin 1 co-treated with mezerein] results in decreased expression of PRKCB protein; [bryostatin 1 co-treated with mezerein] results in decreased expression of PRKCB protein alternative form bryostatin 1 results in decreased expression of PRKCB protein; bryostatin 1 results in decreased expression of PRKCB protein alternative form
|
CTD |
PMID:8892972 |
|
NCBI chr 1:186,263,397...186,594,743
Ensembl chr 1:186,263,447...186,594,740
|
|
G
|
Prkcg
|
protein kinase C, gamma
|
multiple interactions decreases expression
|
ISO
|
[bryostatin 1 co-treated with mezerein] results in decreased expression of PRKCG protein bryostatin 1 results in decreased expression of PRKCG protein
|
CTD |
PMID:8892972 |
|
NCBI chr 1:65,832,851...65,860,676
Ensembl chr 1:74,748,272...74,774,814
|
|
|
G
|
F3
|
coagulation factor III, tissue factor
|
increases expression
|
ISO
|
bryostatin 2 results in increased expression of F3 protein
|
CTD |
PMID:25569083 |
|
NCBI chr 2:212,511,675...212,523,375
Ensembl chr 2:212,511,680...212,523,369
|
|
|
G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
multiple interactions
|
ISO
|
concanamycin A inhibits the reaction [enterotoxin C, staphylococcal results in increased expression of BAX protein]
|
CTD |
PMID:27742270 |
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
|
|
G
|
Bnip3
|
BCL2 interacting protein 3
|
increases expression multiple interactions
|
ISO
|
concanamycin A results in increased expression of BNIP3 mRNA lapatinib inhibits the reaction [concanamycin A results in increased expression of BNIP3 mRNA]
|
CTD |
PMID:25981168 |
|
NCBI chr 1:203,137,778...203,154,962
Ensembl chr 1:203,137,778...203,154,962
|
|
G
|
Casp3
|
caspase 3
|
multiple interactions
|
ISO
|
concanamycin A inhibits the reaction [enterotoxin C, staphylococcal analog results in increased activity of CASP3 protein]; concanamycin A inhibits the reaction [enterotoxin C, staphylococcal results in increased activity of CASP3 protein]
|
CTD |
PMID:27742270 |
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
G
|
Casp9
|
caspase 9
|
multiple interactions
|
ISO
|
concanamycin A inhibits the reaction [enterotoxin C, staphylococcal analog results in increased activity of CASP9 protein]; concanamycin A inhibits the reaction [enterotoxin C, staphylococcal results in increased activity of CASP9 protein]
|
CTD |
PMID:27742270 |
|
Ensembl chr 5:159,391,188...159,409,648
|
|
G
|
F3
|
coagulation factor III, tissue factor
|
increases expression
|
ISO
|
concanamycin A results in increased expression of F3 protein
|
CTD |
PMID:25569083 |
|
NCBI chr 2:212,511,675...212,523,375
Ensembl chr 2:212,511,680...212,523,369
|
|
G
|
Hif1a
|
hypoxia inducible factor 1 subunit alpha
|
increases expression multiple interactions
|
ISO
|
concanamycin A results in increased expression of HIF1A protein lapatinib inhibits the reaction [concanamycin A results in increased expression of HIF1A protein]
|
CTD |
PMID:25981168 |
|
NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:98,359,910...98,405,323
|
|
G
|
Parp1
|
poly (ADP-ribose) polymerase 1
|
multiple interactions
|
ISO
|
[lapatinib co-treated with concanamycin A] results in increased cleavage of PARP1 protein
|
CTD |
PMID:25981168 |
|
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:94,839,433...94,871,567
|
|
|
G
|
Actb
|
actin, beta
|
decreases response to substance
|
ISO
|
ACTB protein mutant form results in decreased susceptibility to latrunculin A
|
CTD |
PMID:16685646 |
|
NCBI chr12:11,663,112...11,666,697
Ensembl chr12:16,776,661...16,780,242
|
|
G
|
Casp3
|
caspase 3
|
increases activity
|
ISO
|
latrunculin A results in increased activity of CASP3 protein
|
CTD |
PMID:16723733 |
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
G
|
Cdh1
|
cadherin 1
|
decreases uptake
|
ISO
|
latrunculin A results in decreased uptake of CDH1 protein modified form
|
CTD |
PMID:20547569 |
|
NCBI chr19:51,402,178...51,471,572
Ensembl chr19:51,402,034...51,471,565
|
|
G
|
Ctnna1
|
catenin alpha 1
|
multiple interactions
|
EXP
|
latrunculin A affects the reaction [FSCN1 protein inhibits the reaction [CTNNA1 protein affects the susceptibility to Cisplatin]]; latrunculin A affects the reaction [FSCN2 protein inhibits the reaction [CTNNA1 protein affects the susceptibility to Cisplatin]]
|
CTD |
PMID:27989596 |
|
NCBI chr18:26,728,246...26,860,911
Ensembl chr18:26,999,820...27,135,007
|
|
G
|
Diaph1
|
diaphanous-related formin 1
|
affects localization
|
ISO
|
latrunculin A affects the localization of DIAPH1 protein
|
CTD |
PMID:22918941 |
|
NCBI chr18:29,920,889...30,020,280
Ensembl chr18:29,920,889...30,020,280
|
|
G
|
Fscn1
|
fascin actin-bundling protein 1
|
multiple interactions
|
EXP
|
latrunculin A affects the reaction [FSCN1 protein inhibits the reaction [CTNNA1 protein affects the susceptibility to Cisplatin]]
|
CTD |
PMID:27989596 |
|
NCBI chr12:16,710,601...16,723,734
Ensembl chr12:16,710,601...16,723,734
|
|
G
|
Fscn2
|
fascin actin-bundling protein 2, retinal
|
multiple interactions
|
EXP
|
latrunculin A affects the reaction [FSCN2 protein inhibits the reaction [CTNNA1 protein affects the susceptibility to Cisplatin]]
|
CTD |
PMID:27989596 |
|
NCBI chr10:105,634,783...105,641,322
Ensembl chr10:106,133,144...106,139,683
|
|
G
|
Il1b
|
interleukin 1 beta
|
multiple interactions
|
ISO
|
latrunculin A inhibits the reaction [Asbestos, Crocidolite results in increased secretion of IL1B protein]; latrunculin A inhibits the reaction [Uric Acid results in increased secretion of IL1B protein]
|
CTD |
PMID:18403674 |
|
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
|
|
G
|
Itgb1
|
integrin subunit beta 1
|
decreases activity
|
ISO
|
latrunculin A results in decreased activity of ITGB1 protein
|
CTD |
PMID:16723733 |
|
NCBI chr19:73,602,277...73,650,271
Ensembl chr19:73,602,126...73,650,269
|
|
G
|
Prlr
|
prolactin receptor
|
decreases uptake
|
ISO
|
latrunculin A results in decreased uptake of PRLR protein
|
CTD |
PMID:20547569 |
|
NCBI chr 2:59,134,147...59,324,719
Ensembl chr 2:60,861,658...61,051,882
|
|
|
G
|
Acta2
|
actin alpha 2, smooth muscle
|
decreases expression multiple interactions
|
EXP
|
latrunculin B results in decreased expression of ACTA2 mRNA latrunculin B inhibits the reaction [RHOA protein results in increased expression of ACTA2 mRNA]
|
CTD |
PMID:11035001 |
|
NCBI chr 1:241,159,723...241,172,503
Ensembl chr 1:241,159,724...241,172,503
|
|
G
|
Aurkb
|
aurora kinase B
|
multiple interactions
|
ISO
|
latrunculin B inhibits the reaction [Silver results in increased phosphorylation of AURKB protein]
|
CTD |
PMID:28499611 |
|
NCBI chr10:54,243,116...54,249,675
Ensembl chr10:54,242,850...54,252,285
|
|
G
|
Gata4
|
GATA binding protein 4
|
multiple interactions
|
EXP
|
latrunculin B inhibits the reaction [Phenylephrine results in increased activity of GATA4 protein]
|
CTD |
PMID:11739382 |
|
NCBI chr15:37,459,601...37,531,291
Ensembl chr15:41,635,572...41,681,609
|
|
G
|
Gdf15
|
growth differentiation factor 15
|
increases expression multiple interactions
|
ISO
|
latrunculin B results in increased expression of GDF15 mRNA; latrunculin B results in increased expression of GDF15 protein [SB 203580 co-treated with 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine] inhibits the reaction [latrunculin B results in increased expression of GDF15 protein]
|
CTD |
PMID:23996089 |
|
NCBI chr16:18,838,436...18,842,022
Ensembl chr16:18,838,436...18,842,022
|
|
G
|
Ifng
|
interferon gamma
|
multiple interactions
|
ISO
|
latrunculin B promotes the reaction [[IFNG protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of NOS2 mRNA]
|
CTD |
PMID:12799187 |
|
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:55,761,736...55,793,216
|
|
G
|
Il1b
|
interleukin 1 beta
|
multiple interactions
|
ISO EXP
|
latrunculin B promotes the reaction [[IFNG protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of NOS2 mRNA] jasplakinolide inhibits the reaction [latrunculin B promotes the reaction [IL1B protein results in increased expression of NOS2 protein]]; latrunculin B promotes the reaction [IL1B protein results in increased expression of NOS2 protein]
|
CTD |
PMID:11502570 PMID:12799187 |
|
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
|
|
G
|
Mapk1
|
mitogen activated protein kinase 1
|
multiple interactions
|
EXP
|
latrunculin B inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK1 protein]
|
CTD |
PMID:11739382 |
|
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825
|
|
G
|
Mapk3
|
mitogen activated protein kinase 3
|
multiple interactions
|
EXP
|
latrunculin B inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK3 protein]
|
CTD |
PMID:11739382 |
|
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411
|
|
G
|
Myod1
|
myogenic differentiation 1
|
decreases expression
|
ISO
|
latrunculin B results in decreased expression of MYOD1 protein
|
CTD |
PMID:15252113 |
|
NCBI chr 1:96,884,864...96,887,574
Ensembl chr 1:106,021,161...106,023,871
|
|
G
|
Nos2
|
nitric oxide synthase 2
|
multiple interactions
|
ISO EXP
|
[latrunculin B results in decreased activity of SRF protein] which results in increased expression of NOS2 protein; latrunculin B promotes the reaction [[IFNG protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of NOS2 mRNA] jasplakinolide inhibits the reaction [latrunculin B promotes the reaction [IL1B protein results in increased expression of NOS2 protein]]; latrunculin B promotes the reaction [IL1B protein results in increased expression of NOS2 protein]
|
CTD |
PMID:11502570 PMID:12799187 |
|
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880
|
|
G
|
Ppp1r9a
|
protein phosphatase 1, regulatory subunit 9A
|
affects localization
|
EXP
|
latrunculin B affects the localization of PPP1R9A protein
|
CTD |
PMID:12052877 |
|
NCBI chr 4:33,936,949...34,258,927
Ensembl chr 4:33,988,827...34,258,927
|
|
G
|
Rhoa
|
ras homolog family member A
|
multiple interactions
|
EXP
|
latrunculin B inhibits the reaction [RHOA protein results in increased expression of ACTA2 mRNA]
|
CTD |
PMID:11035001 |
|
NCBI chr 8:117,870,548...117,904,303
Ensembl chr 8:117,870,270...117,904,302
|
|
G
|
Srf
|
serum response factor
|
decreases activity multiple interactions
|
ISO
|
latrunculin B results in decreased activity of SRF protein [latrunculin B results in decreased activity of SRF protein] which results in increased expression of NOS2 protein
|
CTD |
PMID:11502570 |
|
NCBI chr 9:21,924,050...21,933,338
Ensembl chr 9:21,924,076...21,933,337
|
|
G
|
Tagln
|
transgelin
|
decreases expression
|
EXP
|
latrunculin B results in decreased expression of TAGLN mRNA
|
CTD |
PMID:11035001 |
|
NCBI chr 8:46,224,939...46,230,413
Ensembl chr 8:55,121,301...55,127,563
|
|
G
|
Tnf
|
tumor necrosis factor
|
multiple interactions
|
ISO
|
latrunculin B promotes the reaction [[IFNG protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of NOS2 mRNA]
|
CTD |
PMID:12799187 |
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
|
G
|
Ache
|
acetylcholinesterase
|
decreases activity
|
ISO
|
loganin results in decreased activity of ACHE protein
|
CTD |
PMID:19666019 |
|
NCBI chr12:25,042,882...25,050,608
Ensembl chr12:25,043,461...25,050,410
|
|
G
|
Acta2
|
actin alpha 2, smooth muscle
|
multiple interactions
|
ISO
|
loganin inhibits the reaction [Bleomycin results in increased expression of ACTA2 mRNA]; loganin inhibits the reaction [Bleomycin results in increased expression of ACTA2 protein]
|
CTD |
PMID:35279615 |
|
NCBI chr 1:241,159,723...241,172,503
Ensembl chr 1:241,159,724...241,172,503
|
|
G
|
Bcl2
|
BCL2, apoptosis regulator
|
increases expression
|
ISO
|
loganin results in increased expression of BCL2 mRNA
|
CTD |
PMID:20966881 |
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
|
|
G
|
Casp1
|
caspase 1
|
multiple interactions
|
ISO
|
loganin inhibits the reaction [Glucose results in increased expression of CASP1 mRNA]; loganin inhibits the reaction [Glucose results in increased expression of CASP1 protein] loganin inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in increased expression of CASP1 protein]
|
CTD |
PMID:37473909 |
|
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:10,746,333...10,882,275
|
|
G
|
Casp3
|
caspase 3
|
decreases expression
|
ISO
|
loganin results in decreased expression of CASP3 mRNA
|
CTD |
PMID:20966881 |
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
G
|
Casp9
|
caspase 9
|
decreases expression
|
ISO
|
loganin results in decreased expression of CASP9 mRNA
|
CTD |
PMID:20966881 |
|
Ensembl chr 5:159,391,188...159,409,648
|
|
G
|
Ccl2
|
C-C motif chemokine ligand 2
|
affects expression
|
ISO
|
loganin affects the expression of CCL2 protein
|
CTD |
PMID:21864639 |
|
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875
|
|
G
|
Cyba
|
cytochrome b-245 alpha chain
|
affects expression
|
ISO
|
loganin affects the expression of CYBA protein
|
CTD |
PMID:21864639 |
|
NCBI chr19:67,396,143...67,404,214
Ensembl chr19:67,396,143...67,404,214
|
|
G
|
Gsdmd
|
gasdermin D
|
multiple interactions
|
ISO
|
loganin inhibits the reaction [Glucose results in increased expression of GSDMD mRNA]; loganin inhibits the reaction [Glucose results in increased expression of GSDMD protein] loganin inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in increased expression of GSDMD mRNA]; loganin inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in increased expression of GSDMD protein]
|
CTD |
PMID:37473909 |
|
NCBI chr 7:107,542,489...107,547,051
Ensembl chr 7:109,422,910...109,430,722
|
|
G
|
Hmox1
|
heme oxygenase 1
|
affects expression
|
ISO
|
loganin affects the expression of HMOX1 protein
|
CTD |
PMID:21864639 |
|
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
|
|
G
|
Il18
|
interleukin 18
|
multiple interactions
|
ISO
|
loganin inhibits the reaction [Glucose results in increased expression of IL18 mRNA]; loganin inhibits the reaction [Glucose results in increased expression of IL18 protein] loganin inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in increased expression of and results in increased secretion of IL18 protein]; loganin inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in increased expression of IL18 mRNA]
|
CTD |
PMID:37473909 |
|
NCBI chr 8:59,802,072...59,829,275
Ensembl chr 8:59,809,592...59,831,286
|
|
G
|
Il1b
|
interleukin 1 beta
|
multiple interactions
|
EXP ISO
|
loganin inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA] loganin inhibits the reaction [Glucose results in increased expression of IL1B mRNA]; loganin inhibits the reaction [Glucose results in increased expression of IL1B protein] loganin inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in increased expression of and results in increased secretion of IL1B protein]; loganin inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]
|
CTD |
PMID:35279615 PMID:37473909 |
|
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
|
|
G
|
Il6
|
interleukin 6
|
multiple interactions
|
EXP ISO
|
loganin inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]
|
CTD |
PMID:35279615 |
|
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
|
|
G
|
Lep
|
leptin
|
affects expression
|
ISO
|
loganin affects the expression of LEP protein
|
CTD |
PMID:21864639 |
|
NCBI chr 4:58,626,529...58,640,663
Ensembl chr 4:58,626,523...58,640,661
|
|
G
|
Nfe2l2
|
NFE2 like bZIP transcription factor 2
|
affects expression
|
ISO
|
loganin affects the expression of NFE2L2 protein
|
CTD |
PMID:21864639 |
|
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090
|
|
G
|
Nlrp3
|
NLR family, pyrin domain containing 3
|
multiple interactions
|
ISO
|
loganin inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in increased expression of NLRP3 mRNA]; loganin inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in increased expression of NLRP3 protein] loganin inhibits the reaction [Glucose results in increased expression of NLRP3 mRNA]; loganin inhibits the reaction [Glucose results in increased expression of NLRP3 protein]
|
CTD |
PMID:37473909 |
|
NCBI chr10:44,826,299...44,853,373
Ensembl chr10:44,828,014...44,853,394
|
|
G
|
Nos2
|
nitric oxide synthase 2
|
affects expression
|
ISO
|
loganin affects the expression of NOS2 protein
|
CTD |
PMID:21864639 |
|
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880
|
|
G
|
Nox4
|
NADPH oxidase 4
|
affects expression
|
ISO
|
loganin affects the expression of NOX4 protein
|
CTD |
PMID:21864639 |
|
NCBI chr 1:150,313,736...150,491,480
Ensembl chr 1:150,313,728...150,491,483
|
|
G
|
Ptgs2
|
prostaglandin-endoperoxide synthase 2
|
affects expression
|
ISO
|
loganin affects the expression of PTGS2 protein
|
CTD |
PMID:21864639 |
|
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320
|
|
G
|
Rela
|
RELA proto-oncogene, NF-kB subunit
|
affects expression multiple interactions
|
ISO EXP
|
loganin affects the expression of RELA protein loganin inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased phosphorylation of RELA protein]
|
CTD |
PMID:21864639 PMID:35279615 |
|
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817
|
|
G
|
Stat3
|
signal transducer and activator of transcription 3
|
multiple interactions
|
ISO EXP
|
loganin inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased phosphorylation of STAT3 protein] loganin inhibits the reaction [Lipopolysaccharides results in increased expression of STAT3 protein]
|
CTD |
PMID:35279615 |
|
NCBI chr10:86,311,528...86,363,513
Ensembl chr10:86,311,535...86,363,359
|
|
G
|
Tgfb1
|
transforming growth factor, beta 1
|
multiple interactions
|
ISO
|
loganin inhibits the reaction [Bleomycin results in increased expression of TGFB1 mRNA]
|
CTD |
PMID:35279615 |
|
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:90,324,046...90,340,899
|
|
G
|
Tnf
|
tumor necrosis factor
|
multiple interactions
|
ISO EXP
|
loganin inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]
|
CTD |
PMID:35279615 |
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
G
|
Tnfsf11
|
TNF superfamily member 11
|
decreases expression
|
ISO
|
loganin results in decreased expression of TNFSF11 mRNA
|
CTD |
PMID:20966881 |
|
NCBI chr15:60,083,008...60,114,479
Ensembl chr15:60,083,008...60,114,479
|
|
|
G
|
Il1b
|
interleukin 1 beta
|
multiple interactions
|
ISO
|
manoalide inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]
|
CTD |
PMID:7575673 |
|
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
|
|
G
|
Ptgs2
|
prostaglandin-endoperoxide synthase 2
|
multiple interactions
|
ISO
|
manoalide inhibits the reaction [[Lipopolysaccharides results in increased expression of and results in increased activity of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone]; manoalide inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased activity of PTGS2 protein]
|
CTD |
PMID:7575673 |
|
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320
|
|
G
|
Tnf
|
tumor necrosis factor
|
multiple interactions
|
ISO
|
manoalide inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]
|
CTD |
PMID:7575673 |
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
|
G
|
App
|
amyloid beta precursor protein
|
multiple interactions
|
ISO
|
Monensin inhibits the reaction [[Ketamine results in increased cleavage of APP protein] which results in increased abundance of amyloid beta-protein (1-40)]; Monensin inhibits the reaction [[Ketamine results in increased cleavage of APP protein] which results in increased abundance of amyloid beta-protein (1-42)] Monensin inhibits the reaction [Ketamine results in decreased expression of and results in increased cleavage of APP protein]
|
CTD |
PMID:35378374 |
|
NCBI chr11:37,506,207...37,724,351
Ensembl chr11:37,506,408...37,722,971
|
|
G
|
Atp7a
|
ATPase copper transporting alpha
|
multiple interactions
|
ISO
|
Monensin inhibits the reaction [ATP7A protein affects the localization of Doxorubicin]
|
CTD |
PMID:17510416 |
|
NCBI chr X:75,159,635...75,267,094
Ensembl chr X:75,159,782...75,267,093
|
|
G
|
Bace1
|
beta-secretase 1
|
multiple interactions
|
ISO
|
Monensin inhibits the reaction [Ketamine results in increased expression of and affects the localization of BACE1 protein]
|
CTD |
PMID:35378374 |
|
NCBI chr 8:46,142,060...46,166,268
Ensembl chr 8:55,038,823...55,064,918
|
|
G
|
Bnip3
|
BCL2 interacting protein 3
|
increases expression
|
ISO
|
Monensin results in increased expression of BNIP3 protein
|
CTD |
PMID:30718715 |
|
NCBI chr 1:203,137,778...203,154,962
Ensembl chr 1:203,137,778...203,154,962
|
|
G
|
Casp3
|
caspase 3
|
multiple interactions increases activity
|
ISO
|
Lithium inhibits the reaction [Monensin results in increased activity of CASP3 protein]
|
CTD |
PMID:20799912 |
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
G
|
Casp7
|
caspase 7
|
multiple interactions increases activity
|
ISO
|
Lithium inhibits the reaction [Monensin results in increased activity of CASP7 protein]
|
CTD |
PMID:20799912 |
|
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:265,442,676...265,482,512
|
|
G
|
Csf2
|
colony stimulating factor 2
|
multiple interactions
|
ISO
|
Monensin inhibits the reaction [kaempferol results in increased secretion of CSF2 protein]; Monensin inhibits the reaction [Quercetin results in increased secretion of CSF2 protein]
|
CTD |
PMID:18346843 |
|
NCBI chr10:38,887,692...38,889,673
Ensembl chr10:38,887,692...38,890,031
|
|
G
|
Egf
|
epidermal growth factor
|
multiple interactions
|
EXP
|
[EGF protein co-treated with Monensin] results in increased expression of MYC mRNA
|
CTD |
PMID:12632255 |
|
NCBI chr 2:220,893,660...220,976,331
Ensembl chr 2:220,893,660...220,976,297
|
|
G
|
Il6
|
interleukin 6
|
decreases secretion
|
ISO
|
Monensin results in decreased secretion of IL6 protein
|
CTD |
PMID:11216681 |
|
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
|
|
G
|
Ins1
|
insulin 1
|
decreases degradation
|
EXP
|
Monensin results in decreased degradation of INS1 protein
|
CTD |
PMID:2645939 |
|
NCBI chr 1:261,186,119...261,186,686
Ensembl chr 1:261,186,119...261,186,682
|
|
G
|
Myc
|
MYC proto-oncogene, bHLH transcription factor
|
multiple interactions
|
EXP
|
[EGF protein co-treated with Monensin] results in increased expression of MYC mRNA
|
CTD |
PMID:12632255 |
|
NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:95,483,105...95,488,028
|
|
G
|
Parp1
|
poly (ADP-ribose) polymerase 1
|
increases cleavage
|
ISO
|
Monensin results in increased cleavage of PARP1 protein
|
CTD |
PMID:30718715 |
|
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:94,839,433...94,871,567
|
|
G
|
Slc6a2
|
solute carrier family 6 member 2
|
multiple interactions
|
ISO
|
Monensin promotes the reaction [para-methyl-4-methylaminorex inhibits the reaction [SLC6A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium]]
|
CTD |
PMID:29908239 |
|
NCBI chr19:30,183,289...30,228,292
Ensembl chr19:30,183,383...30,223,348
|
|
G
|
Slc6a3
|
solute carrier family 6 member 3
|
multiple interactions
|
ISO
|
Monensin promotes the reaction [para-methyl-4-methylaminorex inhibits the reaction [SLC6A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium]]
|
CTD |
PMID:29908239 |
|
NCBI chr 1:31,537,990...31,578,962
Ensembl chr 1:31,537,990...31,578,962
|
|
G
|
Slc6a4
|
solute carrier family 6 member 4
|
multiple interactions
|
ISO
|
Monensin promotes the reaction [para-methyl-4-methylaminorex inhibits the reaction [SLC6A4 protein results in increased uptake of Serotonin]]
|
CTD |
PMID:29908239 |
|
NCBI chr10:62,322,688...62,357,060
Ensembl chr10:62,324,254...62,357,056
|
|
G
|
Trpm2
|
transient receptor potential cation channel, subfamily M, member 2
|
decreases expression increases expression multiple interactions
|
ISO
|
Monensin results in decreased expression of TRPM2 protein alternative form Monensin results in increased expression of TRPM2 protein alternative form Lithium inhibits the reaction [Monensin results in increased expression of TRPM2 protein alternative form]
|
CTD |
PMID:20799912 |
|
NCBI chr20:10,703,190...10,752,795
Ensembl chr20:10,704,482...10,752,802
|
|
G
|
Zeb1
|
zinc finger E-box binding homeobox 1
|
increases response to substance
|
ISO
|
ZEB1 protein results in increased susceptibility to Monensin
|
CTD |
PMID:30718715 |
|
NCBI chr17:56,644,397...56,811,155
Ensembl chr17:56,644,397...56,810,745
|
|
|
G
|
Alb
|
albumin
|
multiple interactions
|
ISO
|
oridonin binds to and affects the folding of ALB protein
|
CTD |
PMID:25816984 |
|
NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,891,582...17,911,865
|
|
G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
multiple interactions
|
EXP
|
oridonin inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of BAX mRNA]; oridonin inhibits the reaction [Kainic Acid results in increased expression of BAX mRNA]
|
CTD |
PMID:31430510 |
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
|
|
G
|
Bcl2
|
BCL2, apoptosis regulator
|
decreases expression multiple interactions
|
ISO EXP
|
oridonin analog results in decreased expression of BCL2 protein; oridonin results in decreased expression of BCL2 protein oridonin inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 mRNA]; oridonin inhibits the reaction [Kainic Acid results in decreased expression of BCL2 mRNA]
|
CTD |
PMID:16019488 PMID:31430510 PMID:31594861 |
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
|
|
G
|
Birc5
|
baculoviral IAP repeat-containing 5
|
decreases expression
|
ISO
|
oridonin analog results in decreased expression of BIRC5 protein
|
CTD |
PMID:31594861 |
|
NCBI chr10:103,567,369...103,580,069
Ensembl chr10:103,572,080...103,582,155
|
|
G
|
Casp3
|
caspase 3
|
increases cleavage multiple interactions
|
ISO EXP
|
oridonin results in increased cleavage of CASP3 protein oridonin inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased activity of CASP3 protein]; oridonin inhibits the reaction [Kainic Acid results in increased activity of CASP3 protein]
|
CTD |
PMID:16019488 PMID:31430510 |
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
G
|
Cat
|
catalase
|
multiple interactions
|
EXP
|
oridonin inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased activity of CAT protein]; oridonin inhibits the reaction [Kainic Acid results in decreased activity of CAT protein]
|
CTD |
PMID:31430510 |
|
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526
|
|
G
|
Ccnd1
|
cyclin D1
|
decreases expression
|
ISO
|
oridonin analog results in decreased expression of CCND1 protein
|
CTD |
PMID:31594861 |
|
NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810
|
|
G
|
Cdh1
|
cadherin 1
|
increases expression multiple interactions
|
ISO
|
oridonin results in increased expression of CDH1 mRNA; oridonin results in increased expression of CDH1 protein oridonin inhibits the reaction [TGFB1 protein results in increased expression of CDH1 mRNA]; oridonin inhibits the reaction [TGFB1 protein results in increased expression of CDH1 protein]
|
CTD |
PMID:30243739 |
|
NCBI chr19:51,402,178...51,471,572
Ensembl chr19:51,402,034...51,471,565
|
|
G
|
Cdh2
|
cadherin 2
|
multiple interactions decreases expression
|
ISO
|
oridonin inhibits the reaction [TGFB1 protein results in decreased expression of CDH2 mRNA]; oridonin inhibits the reaction [TGFB1 protein results in decreased expression of CDH2 protein] oridonin results in decreased expression of CDH2 mRNA; oridonin results in decreased expression of CDH2 protein
|
CTD |
PMID:30243739 |
|
NCBI chr18:8,051,097...8,265,288
Ensembl chr18:8,051,097...8,265,288
|
|
G
|
Egf
|
epidermal growth factor
|
multiple interactions
|
ISO
|
oridonin analog inhibits the reaction [EGF protein promotes the reaction [EGFR protein modified form binds to STAT3 protein]]; oridonin analog inhibits the reaction [EGF protein promotes the reaction [SRC protein modified form binds to STAT3 protein]]; oridonin analog inhibits the reaction [EGF protein results in increased phosphorylation of STAT3 protein]
|
CTD |
PMID:31594861 |
|
NCBI chr 2:220,893,660...220,976,331
Ensembl chr 2:220,893,660...220,976,297
|
|
G
|
Egfr
|
epidermal growth factor receptor
|
multiple interactions
|
ISO
|
oridonin analog inhibits the reaction [EGF protein promotes the reaction [EGFR protein modified form binds to STAT3 protein]]; oridonin analog inhibits the reaction [EGFR protein results in increased phosphorylation of STAT3 protein]
|
CTD |
PMID:31594861 |
|
NCBI chr14:95,378,626...95,551,358
Ensembl chr14:95,378,626...95,551,358
|
|
G
|
Glul
|
glutamate-ammonia ligase
|
multiple interactions
|
EXP
|
oridonin inhibits the reaction [Kainic Acid results in decreased expression of GLUL mRNA]
|
CTD |
PMID:31430510 |
|
NCBI chr13:68,519,500...68,585,554
Ensembl chr13:68,576,067...68,585,520
|
|
G
|
Gsr
|
glutathione-disulfide reductase
|
multiple interactions
|
EXP
|
oridonin inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased activity of GSR protein]; oridonin inhibits the reaction [Kainic Acid results in decreased activity of GSR protein]
|
CTD |
PMID:31430510 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:65,185,574...65,228,394
|
|
G
|
Hmox1
|
heme oxygenase 1
|
increases expression multiple interactions
|
EXP
|
oridonin results in increased expression of HMOX1 mRNA; oridonin results in increased expression of HMOX1 protein oridonin results in increased expression of and results in increased activity of HMOX1 protein
|
CTD |
PMID:18351433 |
|
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
|
|
G
|
Ifng
|
interferon gamma
|
decreases expression multiple interactions
|
EXP ISO
|
oridonin results in decreased expression of IFNG protein oridonin analog inhibits the reaction [IFNG protein results in increased phosphorylation of STAT3 protein]
|
CTD |
PMID:18351433 PMID:31594861 |
|
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:55,761,736...55,793,216
|
|
G
|
Il10
|
interleukin 10
|
increases expression
|
EXP
|
oridonin results in increased expression of IL10 protein
|
CTD |
PMID:18351433 |
|
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:45,025,087...45,029,580
|
|
G
|
Il1b
|
interleukin 1 beta
|
multiple interactions
|
EXP
|
oridonin inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of IL1B protein]; oridonin inhibits the reaction [Kainic Acid results in increased expression of IL1B protein]
|
CTD |
PMID:31430510 |
|
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
|
|
G
|
Il2
|
interleukin 2
|
decreases expression
|
EXP
|
oridonin results in decreased expression of IL2 protein
|
CTD |
PMID:18351433 |
|
NCBI chr 2:121,932,968...121,937,672
Ensembl chr 2:121,932,968...121,937,672
|
|
G
|
Il6
|
interleukin 6
|
multiple interactions
|
EXP ISO
|
oridonin inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of IL6 protein]; oridonin inhibits the reaction [Kainic Acid results in increased expression of IL6 protein] oridonin analog inhibits the reaction [IL6 protein affects the localization of STAT3 protein]; oridonin analog inhibits the reaction [IL6 protein promotes the reaction [JAK1 protein modified form binds to STAT3 protein]]; oridonin analog inhibits the reaction [IL6 protein promotes the reaction [STAT1 protein binds to STAT3 protein]]; oridonin analog inhibits the reaction [IL6 protein promotes the reaction [STAT3 protein binds to STAT3 protein]]; oridonin analog inhibits the reaction [IL6 protein results in increased expression of STAT3 mRNA]; oridonin analog inhibits the reaction [IL6 protein results in increased phosphorylation of STAT3 protein]
|
CTD |
PMID:31430510 PMID:31594861 |
|
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
|
|
G
|
Impdh2
|
inosine monophosphate dehydrogenase 2
|
decreases activity
|
ISO
|
oridonin results in decreased activity of IMPDH2 protein
|
CTD |
PMID:37871880 |
|
NCBI chr 8:109,256,705...109,261,365
Ensembl chr 8:118,135,262...118,139,873
|
|
G
|
Jak1
|
Janus kinase 1
|
multiple interactions
|
ISO
|
oridonin analog inhibits the reaction [IL6 protein promotes the reaction [JAK1 protein modified form binds to STAT3 protein]]; oridonin analog inhibits the reaction [JAK1 protein results in increased phosphorylation of STAT3 protein]
|
CTD |
PMID:31594861 |
|
NCBI chr 5:120,895,606...121,004,207
Ensembl chr 5:120,896,046...120,996,758
|
|
G
|
Mki67
|
marker of proliferation Ki-67
|
decreases expression
|
ISO
|
oridonin analog results in decreased expression of MKI67 protein
|
CTD |
PMID:31594861 |
|
NCBI chr 1:199,926,150...199,952,847
Ensembl chr 1:199,926,150...199,952,593
|
|
G
|
Mmp2
|
matrix metallopeptidase 2
|
decreases expression
|
ISO
|
oridonin analog results in decreased expression of MMP2 protein
|
CTD |
PMID:31594861 |
|
NCBI chr19:30,327,643...30,355,856
Ensembl chr19:30,327,643...30,355,856
|
|
G
|
Mmp9
|
matrix metallopeptidase 9
|
decreases expression
|
ISO
|
oridonin analog results in decreased expression of MMP9 protein
|
CTD |
PMID:31594861 |
|
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442
|
|
G
|
Myc
|
MYC proto-oncogene, bHLH transcription factor
|
decreases expression
|
ISO
|
oridonin analog results in decreased expression of MYC protein
|
CTD |
PMID:31594861 |
|
NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:95,483,105...95,488,028
|
|
G
|
Parp1
|
poly (ADP-ribose) polymerase 1
|
increases cleavage multiple interactions
|
ISO
|
oridonin results in increased cleavage of PARP1 protein oridonin analog results in decreased expression of and results in increased cleavage of PARP1 protein
|
CTD |
PMID:16019488 PMID:31594861 |
|
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:94,839,433...94,871,567
|
|
G
|
Ptgs2
|
prostaglandin-endoperoxide synthase 2
|
multiple interactions
|
EXP
|
oridonin inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of PTGS2 protein]; oridonin inhibits the reaction [Kainic Acid results in increased expression of PTGS2 protein]
|
CTD |
PMID:31430510 |
|
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320
|
|
G
|
Rangap1
|
RAN GTPase activating protein 1
|
multiple interactions
|
ISO
|
oridonin results in decreased expression of and affects the localization of RANGAP1 protein
|
CTD |
PMID:25746355 |
|
NCBI chr 7:115,104,820...115,130,564
Ensembl chr 7:115,104,823...115,130,564
|
|
G
|
Smad2
|
SMAD family member 2
|
multiple interactions
|
ISO
|
oridonin inhibits the reaction [TGFB1 protein results in increased phosphorylation of SMAD2 protein]
|
CTD |
PMID:30243739 |
|
NCBI chr18:72,124,792...72,193,345
Ensembl chr18:72,124,863...72,187,388
|
|
G
|
Smad3
|
SMAD family member 3
|
multiple interactions
|
ISO
|
oridonin inhibits the reaction [TGFB1 protein results in increased phosphorylation of SMAD3 protein]
|
CTD |
PMID:30243739 |
|
NCBI chr 8:73,022,204...73,132,324
Ensembl chr 8:73,024,760...73,132,324
|
|
G
|
Snai1
|
snail family transcriptional repressor 1
|
decreases expression multiple interactions
|
ISO
|
oridonin results in decreased expression of SNAI1 mRNA; oridonin results in decreased expression of SNAI1 protein oridonin inhibits the reaction [TGFB1 protein results in decreased expression of SNAI1 mRNA]; oridonin inhibits the reaction [TGFB1 protein results in decreased expression of SNAI1 protein]
|
CTD |
PMID:30243739 |
|
NCBI chr 3:156,248,479...156,252,969
|
|
G
|
Snai2
|
snail family transcriptional repressor 2
|
decreases expression multiple interactions
|
ISO
|
oridonin results in decreased expression of SNAI2 mRNA; oridonin results in decreased expression of SNAI2 protein oridonin inhibits the reaction [TGFB1 protein results in decreased expression of SNAI2 mRNA]; oridonin inhibits the reaction [TGFB1 protein results in decreased expression of SNAI2 protein]
|
CTD |
PMID:30243739 |
|
NCBI chr11:99,686,934...99,690,349
Ensembl chr11:99,686,934...99,690,349
|
|
G
|
Src
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
multiple interactions
|
ISO
|
oridonin analog inhibits the reaction [EGF protein promotes the reaction [SRC protein modified form binds to STAT3 protein]]; oridonin analog inhibits the reaction [SRC protein results in increased phosphorylation of STAT3 protein]
|
CTD |
PMID:31594861 |
|
NCBI chr 3:166,511,616...166,559,463
Ensembl chr 3:166,511,985...166,559,462
|
|
G
|
Stat1
|
signal transducer and activator of transcription 1
|
multiple interactions
|
ISO
|
oridonin analog inhibits the reaction [IL6 protein promotes the reaction [STAT1 protein binds to STAT3 protein]]
|
CTD |
PMID:31594861 |
|
NCBI chr 9:56,911,522...56,951,926
Ensembl chr 9:56,911,523...57,077,346
|
|
G
|
Stat3
|
signal transducer and activator of transcription 3
|
multiple interactions decreases phosphorylation
|
ISO
|
oridonin analog inhibits the reaction [IFNG protein results in increased phosphorylation of STAT3 protein] oridonin analog results in decreased phosphorylation of STAT3 protein oridonin analog binds to and results in decreased stability of STAT3 protein; oridonin analog inhibits the reaction [EGF protein promotes the reaction [EGFR protein modified form binds to STAT3 protein]]; oridonin analog inhibits the reaction [EGF protein promotes the reaction [SRC protein modified form binds to STAT3 protein]]; oridonin analog inhibits the reaction [EGF protein results in increased phosphorylation of STAT3 protein]; oridonin analog inhibits the reaction [EGFR protein results in increased phosphorylation of STAT3 protein]; oridonin analog inhibits the reaction [IFNG protein results in increased phosphorylation of STAT3 protein]; oridonin analog inhibits the reaction [IL6 protein affects the localization of STAT3 protein]; oridonin analog inhibits the reaction [IL6 protein promotes the reaction [JAK1 protein modified form binds to STAT3 protein]]; oridonin analog inhibits the reaction [IL6 protein promotes the reaction [STAT1 protein binds to STAT3 protein]]; oridonin analog inhibits the reaction [IL6 protein promotes the reaction [STAT3 protein binds to STAT3 protein]]; oridonin analog inhibits the reaction [IL6 protein results in increased expression of STAT3 mRNA]; oridonin analog inhibits the reaction [IL6 protein results in increased phosphorylation of STAT3 protein]; oridonin analog inhibits the reaction [JAK1 protein results in increased phosphorylation of STAT3 protein]; oridonin analog inhibits the reaction [SRC protein results in increased phosphorylation of STAT3 protein]
|
CTD |
PMID:31594861 |
|
NCBI chr10:86,311,528...86,363,513
Ensembl chr10:86,311,535...86,363,359
|
|
G
|
Tgfb1
|
transforming growth factor, beta 1
|
increases expression multiple interactions
|
EXP ISO
|
oridonin results in increased expression of TGFB1 protein oridonin inhibits the reaction [TGFB1 protein results in decreased expression of CDH2 mRNA]; oridonin inhibits the reaction [TGFB1 protein results in decreased expression of CDH2 protein]; oridonin inhibits the reaction [TGFB1 protein results in decreased expression of SNAI1 mRNA]; oridonin inhibits the reaction [TGFB1 protein results in decreased expression of SNAI1 protein]; oridonin inhibits the reaction [TGFB1 protein results in decreased expression of SNAI2 mRNA]; oridonin inhibits the reaction [TGFB1 protein results in decreased expression of SNAI2 protein]; oridonin inhibits the reaction [TGFB1 protein results in decreased expression of VIM mRNA]; oridonin inhibits the reaction [TGFB1 protein results in decreased expression of VIM protein]; oridonin inhibits the reaction [TGFB1 protein results in increased expression of CDH1 mRNA]; oridonin inhibits the reaction [TGFB1 protein results in increased expression of CDH1 protein]; oridonin inhibits the reaction [TGFB1 protein results in increased phosphorylation of SMAD2 protein]; oridonin inhibits the reaction [TGFB1 protein results in increased phosphorylation of SMAD3 protein]
|
CTD |
PMID:18351433 PMID:30243739 |
|
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:90,324,046...90,340,899
|
|
G
|
Th
|
tyrosine hydroxylase
|
multiple interactions
|
EXP
|
oridonin inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of TH mRNA]
|
CTD |
PMID:31430510 |
|
NCBI chr 1:207,500,959...207,508,276
Ensembl chr 1:207,500,962...207,557,227
|
|
G
|
Tnf
|
tumor necrosis factor
|
multiple interactions
|
EXP
|
oridonin inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of TNF protein]; oridonin inhibits the reaction [Kainic Acid results in increased expression of TNF protein]
|
CTD |
PMID:31430510 |
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
G
|
Vim
|
vimentin
|
multiple interactions decreases expression
|
ISO
|
oridonin inhibits the reaction [TGFB1 protein results in decreased expression of VIM mRNA]; oridonin inhibits the reaction [TGFB1 protein results in decreased expression of VIM protein] oridonin results in decreased expression of VIM mRNA; oridonin results in decreased expression of VIM protein
|
CTD |
PMID:30243739 |
|
NCBI chr17:81,577,261...81,585,746
Ensembl chr17:81,568,272...81,585,746
|
|
|
G
|
Adra1a
|
adrenoceptor alpha 1A
|
decreases expression
|
ISO
|
Patulin results in decreased expression of ADRA1A mRNA
|
CTD |
PMID:38806716 |
|
NCBI chr15:45,005,648...45,111,416
Ensembl chr15:45,005,799...45,102,534
|
|
G
|
Adra2a
|
adrenoceptor alpha 2A
|
decreases expression
|
ISO
|
Patulin results in decreased expression of ADRA2A mRNA
|
CTD |
PMID:38806716 |
|
NCBI chr 1:263,066,780...263,069,580
Ensembl chr 1:263,065,278...263,069,871
|
|
G
|
Adra2b
|
adrenoceptor alpha 2B
|
affects expression
|
ISO
|
Patulin affects the expression of ADRA2B mRNA
|
CTD |
PMID:38806716 |
|
NCBI chr 3:114,585,174...114,589,220
Ensembl chr 3:135,038,474...135,042,525
|
|
G
|
Akt1
|
AKT serine/threonine kinase 1
|
decreases phosphorylation multiple interactions
|
ISO
|
Patulin results in decreased phosphorylation of AKT1 protein Acetylcysteine inhibits the reaction [Patulin results in decreased phosphorylation of AKT1 protein]
|
CTD |
PMID:29604266 |
|
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610
|
|
G
|
Akt3
|
AKT serine/threonine kinase 3
|
increases expression
|
ISO
|
Patulin results in increased expression of AKT3 mRNA
|
CTD |
PMID:38806716 |
|
NCBI chr13:91,475,839...91,758,060
Ensembl chr13:91,475,839...91,748,020
|
|
G
|
Atf3
|
activating transcription factor 3
|
increases expression
|
ISO
|
Patulin results in increased expression of ATF3 mRNA
|
CTD |
PMID:21844328 |
|
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:105,282,440...105,295,750
|
|
G
|
Atg5
|
autophagy related 5
|
multiple interactions
|
ISO
|
ATG5 protein affects the reaction [Patulin results in increased expression of and results in increased cleavage of GSDMD protein]; ATG5 protein affects the reaction [Patulin results in increased expression of IL1B protein]
|
CTD |
PMID:33217525 |
|
NCBI chr20:49,380,835...49,471,826
Ensembl chr20:49,380,813...49,471,821
|
|
G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
increases expression
|
ISO
|
Patulin results in increased expression of BAX protein
|
CTD |
PMID:19000704 |
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
|
|
G
|
Bcl2l11
|
Bcl2-like 11
|
increases expression
|
ISO
|
Patulin results in increased expression of BCL2L11 mRNA
|
CTD |
PMID:21844328 |
|
NCBI chr 3:135,820,042...135,857,330
Ensembl chr 3:135,817,562...135,960,695
|
|
G
|
Becn1
|
beclin 1
|
increases phosphorylation multiple interactions
|
ISO
|
Patulin results in increased phosphorylation of BECN1 protein Patulin promotes the reaction [BECN1 protein modified form binds to SLC7A11 protein]
|
CTD |
PMID:35772596 |
|
NCBI chr10:86,731,649...86,747,002
Ensembl chr10:86,731,650...86,747,002
|
|
G
|
Bid
|
BH3 interacting domain death agonist
|
increases expression
|
ISO
|
Patulin results in increased expression of BID mRNA
|
CTD |
PMID:21844328 |
|
NCBI chr 4:155,785,366...155,808,775
Ensembl chr 4:155,785,377...155,808,275
|
|
G
|
Casp1
|
caspase 1
|
multiple interactions increases expression
|
ISO
|
3-methyladenine inhibits the reaction [Patulin results in increased expression of CASP1 protein]; CA 074 methyl ester inhibits the reaction [Patulin results in increased expression of CASP1 protein]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [Patulin results in increased expression of CASP1 protein]
|
CTD |
PMID:33217525 |
|
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:10,746,333...10,882,275
|
|
G
|
Casp3
|
caspase 3
|
increases activity multiple interactions
|
ISO
|
Patulin results in increased activity of CASP3 protein diphenyleneiodonium inhibits the reaction [Patulin results in increased activity of CASP3 protein]
|
CTD |
PMID:19000704 PMID:25577197 PMID:26095701 PMID:33577942 |
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
G
|
Casp8
|
caspase 8
|
increases activity multiple interactions
|
ISO
|
Patulin results in increased activity of CASP8 protein diphenyleneiodonium inhibits the reaction [Patulin results in increased activity of CASP8 protein]
|
CTD |
PMID:33577942 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:67,758,033...67,806,699
|
|
G
|
Casp9
|
caspase 9
|
increases activity multiple interactions
|
ISO
|
Patulin results in increased activity of CASP9 protein diphenyleneiodonium inhibits the reaction [Patulin results in increased activity of CASP9 protein]
|
CTD |
PMID:33577942 |
|
Ensembl chr 5:159,391,188...159,409,648
|
|
G
|
Cat
|
catalase
|
decreases activity multiple interactions increases activity decreases response to substance
|
ISO
|
Patulin results in decreased activity of CAT protein diphenyleneiodonium inhibits the reaction [Patulin results in decreased activity of CAT protein] Patulin results in increased activity of CAT protein CAT protein results in decreased susceptibility to Patulin crocin inhibits the reaction [Patulin results in increased activity of CAT protein]; Tetradecanoylphorbol Acetate inhibits the reaction [Patulin results in decreased activity of CAT protein]
|
CTD |
PMID:17090621 PMID:21964610 PMID:26095701 PMID:26584762 PMID:33577942 |
|
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526
|
|
G
|
Ccnb1
|
cyclin B1
|
decreases degradation
|
ISO
|
Patulin results in decreased degradation of CCNB1 protein
|
CTD |
PMID:34718031 |
|
NCBI chr 2:33,646,252...33,655,225
Ensembl chr 2:33,646,252...33,655,225
|
|
G
|
Cdh1
|
cadherin 1
|
decreases expression
|
EXP
|
Patulin results in decreased expression of CDH1 protein
|
CTD |
PMID:34896196 |
|
NCBI chr19:51,402,178...51,471,572
Ensembl chr19:51,402,034...51,471,565
|
|
G
|
Cdh2
|
cadherin 2
|
increases expression
|
EXP
|
Patulin results in increased expression of CDH2 protein
|
CTD |
PMID:34896196 |
|
NCBI chr18:8,051,097...8,265,288
Ensembl chr18:8,051,097...8,265,288
|
|
G
|
Cdkn1a
|
cyclin-dependent kinase inhibitor 1A
|
increases expression
|
ISO
|
Patulin results in increased expression of CDKN1A protein
|
CTD |
PMID:19000704 |
|
NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969
|
|
G
|
Cldn1
|
claudin 1
|
affects localization
|
ISO
|
Patulin affects the localization of CLDN1 protein
|
CTD |
PMID:19013514 |
|
NCBI chr11:87,926,376...87,941,533
Ensembl chr11:87,926,337...87,941,529
|
|
G
|
Cldn3
|
claudin 3
|
affects localization
|
ISO
|
Patulin affects the localization of CLDN3 protein
|
CTD |
PMID:19013514 |
|
NCBI chr12:21,708,538...21,710,010
Ensembl chr12:27,345,076...27,348,841
|
|
G
|
Cldn4
|
claudin 4
|
affects localization
|
ISO
|
Patulin affects the localization of CLDN4 protein
|
CTD |
PMID:19013514 |
|
NCBI chr12:21,751,638...21,753,436
Ensembl chr12:27,387,981...27,389,958
|
|
G
|
Clk1
|
CDC-like kinase 1
|
decreases expression
|
ISO
|
Patulin results in decreased expression of CLK1 mRNA
|
CTD |
PMID:27913847 |
|
NCBI chr 9:59,947,774...59,959,002
Ensembl chr 9:67,441,952...67,451,187
|
|
G
|
Clu
|
clusterin
|
increases expression
|
EXP
|
Patulin results in increased expression of CLU protein
|
CTD |
PMID:34896196 |
|
NCBI chr15:44,336,619...44,375,861
Ensembl chr15:44,359,914...44,375,860
|
|
G
|
Ctsb
|
cathepsin B
|
increases secretion multiple interactions
|
ISO
|
Patulin results in increased secretion of CTSB protein 3-methyladenine inhibits the reaction [Patulin results in increased secretion of CTSB protein]; CA 074 methyl ester inhibits the reaction [Patulin results in increased secretion of CTSB protein]
|
CTD |
PMID:33217525 |
|
NCBI chr15:41,565,607...41,586,479
Ensembl chr15:41,565,611...41,586,478
|
|
G
|
Cybb
|
cytochrome b-245 beta chain
|
increases expression
|
ISO
|
Patulin results in increased expression of CYBB mRNA; Patulin results in increased expression of CYBB protein
|
CTD |
PMID:33577942 |
|
NCBI chr X:16,030,596...16,065,065
Ensembl chr X:16,030,596...16,065,065
|
|
G
|
Ddit3
|
DNA-damage inducible transcript 3
|
increases expression
|
ISO
|
Patulin results in increased expression of DDIT3 mRNA
|
CTD |
PMID:21844328 PMID:25577197 |
|
NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:65,005,501...65,006,509
|
|
G
|
Dnmt1
|
DNA methyltransferase 1
|
increases expression
|
ISO
|
Patulin results in increased expression of DNMT1 mRNA
|
CTD |
PMID:38806716 |
|
NCBI chr 8:27,716,797...27,763,405
Ensembl chr 8:27,716,797...27,763,119
|
|
G
|
Dnmt3a
|
DNA methyltransferase 3 alpha
|
decreases expression
|
ISO
|
Patulin results in decreased expression of DNMT3A mRNA
|
CTD |
PMID:38806716 |
|
NCBI chr 6:32,507,316...32,621,678
Ensembl chr 6:32,512,070...32,614,970
|
|
G
|
Dnmt3b
|
DNA methyltransferase 3 beta
|
decreases expression
|
ISO
|
Patulin results in decreased expression of DNMT3B mRNA
|
CTD |
PMID:38806716 |
|
NCBI chr 3:162,590,777...162,629,313
Ensembl chr 3:162,604,037...162,629,313
|
|
G
|
Fos
|
Fos proto-oncogene, AP-1 transcription factor subunit
|
increases expression multiple interactions
|
ISO EXP
|
Patulin results in increased expression of FOS protein Patulin promotes the reaction [FOS protein binds to TGFB1 promoter]; pyrazolanthrone inhibits the reaction [Patulin results in increased expression of FOS protein]
|
CTD |
PMID:21964610 PMID:34896196 |
|
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598
|
|
G
|
Gpt
|
glutamic--pyruvic transaminase
|
increases expression
|
ISO
|
Patulin results in increased expression of GPT protein
|
CTD |
PMID:33217525 |
|
NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:110,296,206...110,300,160
|
|
G
|
Gsdmd
|
gasdermin D
|
multiple interactions
|
ISO
|
ATG5 protein affects the reaction [Patulin results in increased expression of and results in increased cleavage of GSDMD protein]; N-acetyl-tyrosyl-valyl-alanyl-aspartyl chloromethyl ketone inhibits the reaction [Patulin results in increased expression of and results in increased cleavage of GSDMD protein]; Patulin results in increased expression of and results in increased cleavage of GSDMD protein
|
CTD |
PMID:33217525 |
|
NCBI chr 7:107,542,489...107,547,051
Ensembl chr 7:109,422,910...109,430,722
|
|
G
|
Gsr
|
glutathione-disulfide reductase
|
decreases activity multiple interactions
|
ISO
|
Patulin results in decreased activity of GSR protein diphenyleneiodonium inhibits the reaction [Patulin results in decreased activity of GSR protein]
|
CTD |
PMID:21964610 PMID:33577942 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:65,185,574...65,228,394
|
|
G
|
Havcr1
|
hepatitis A virus cellular receptor 1
|
increases expression
|
EXP
|
Patulin results in increased expression of HAVCR1 protein
|
CTD |
PMID:34896196 |
|
NCBI chr10:31,619,914...31,652,955
Ensembl chr10:31,619,897...31,653,268
|
|
G
|
Hspa5
|
heat shock protein family A (Hsp70) member 5
|
increases expression
|
ISO
|
Patulin results in increased expression of HSPA5 protein
|
CTD |
PMID:25577197 |
|
NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:38,453,041...38,458,790
|
|
G
|
Ifng
|
interferon gamma
|
multiple interactions decreases expression decreases secretion
|
ISO
|
[Patulin results in decreased abundance of Glutathione] which results in decreased secretion of IFNG protein Patulin results in decreased expression of IFNG mRNA Patulin results in decreased secretion of IFNG protein
|
CTD |
PMID:12112629 PMID:18214930 |
|
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:55,761,736...55,793,216
|
|
G
|
Il10
|
interleukin 10
|
multiple interactions
|
ISO
|
[Patulin results in decreased abundance of Glutathione] which results in decreased secretion of IL10 protein
|
CTD |
PMID:18214930 |
|
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:45,025,087...45,029,580
|
|
G
|
Il13
|
interleukin 13
|
multiple interactions
|
ISO
|
[Patulin results in decreased abundance of Glutathione] which results in decreased secretion of IL13 protein
|
CTD |
PMID:18214930 |
|
NCBI chr10:38,290,926...38,293,483
Ensembl chr10:38,290,926...38,293,483
|
|
G
|
Il18
|
interleukin 18
|
multiple interactions
|
ISO
|
3-methyladenine inhibits the reaction [Patulin results in increased expression of IL18 protein]
|
CTD |
PMID:33217525 |
|
NCBI chr 8:59,802,072...59,829,275
Ensembl chr 8:59,809,592...59,831,286
|
|
G
|
Il1b
|
interleukin 1 beta
|
multiple interactions increases expression
|
ISO
|
3-methyladenine inhibits the reaction [Patulin results in increased expression of IL1B protein]; ATG5 protein affects the reaction [Patulin results in increased expression of IL1B protein]; CA 074 methyl ester inhibits the reaction [Patulin results in increased expression of IL1B protein]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [Patulin results in increased expression of IL1B protein]; N-acetyl-tyrosyl-valyl-alanyl-aspartyl chloromethyl ketone inhibits the reaction [Patulin results in increased expression of IL1B protein]; Patulin inhibits the reaction [IL1B protein results in increased expression of CXCL8 protein]
|
CTD |
PMID:18308354 PMID:33217525 |
|
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
|
|
G
|
Il20
|
interleukin 20
|
increases expression
|
ISO
|
Patulin results in increased expression of IL20 protein
|
CTD |
PMID:33217525 |
|
NCBI chr13:42,380,981...42,384,625
Ensembl chr13:44,933,249...44,936,893
|
|
G
|
Il4
|
interleukin 4
|
affects secretion multiple interactions increases expression
|
ISO
|
Patulin affects the secretion of IL4 protein [Patulin results in decreased abundance of Glutathione] which results in decreased secretion of IL4 protein Patulin results in increased expression of IL4 mRNA
|
CTD |
PMID:12112629 PMID:18214930 |
|
NCBI chr10:38,272,003...38,277,549
Ensembl chr10:38,272,003...38,277,549
|
|
G
|
Jun
|
Jun proto-oncogene, AP-1 transcription factor subunit
|
increases expression multiple interactions
|
ISO EXP
|
Patulin results in increased expression of JUN protein Patulin promotes the reaction [JUN protein binds to TGFB1 promoter]; pyrazolanthrone inhibits the reaction [Patulin results in increased expression of JUN protein]
|
CTD |
PMID:21964610 PMID:34896196 |
|
NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:114,973,151...115,013,285
|
|
G
|
Mapk1
|
mitogen activated protein kinase 1
|
increases phosphorylation increases expression multiple interactions
|
ISO EXP
|
Patulin results in increased phosphorylation of MAPK1 protein Patulin results in increased expression of MAPK1 mRNA; Patulin results in increased expression of MAPK1 protein 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Patulin results in increased phosphorylation of MAPK1 protein]
|
CTD |
PMID:17090621 PMID:21964610 PMID:34896196 PMID:38806716 |
|
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825
|
|
G
|
Mapk14
|
mitogen activated protein kinase 14
|
increases expression
|
ISO
|
Patulin results in increased expression of MAPK14 mRNA
|
CTD |
PMID:38806716 |
|
NCBI chr20:6,751,288...6,812,294
Ensembl chr20:6,751,357...6,812,294
|
|
G
|
Mapk3
|
mitogen activated protein kinase 3
|
increases phosphorylation increases expression multiple interactions
|
ISO EXP
|
Patulin results in increased phosphorylation of MAPK3 protein Patulin results in increased expression of MAPK3 protein 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Patulin results in increased phosphorylation of MAPK3 protein]
|
CTD |
PMID:17090621 PMID:21964610 PMID:34896196 PMID:38806716 |
|
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411
|
|
G
|
Mapk8
|
mitogen-activated protein kinase 8
|
increases phosphorylation
|
EXP
|
Patulin results in increased phosphorylation of MAPK8 protein
|
CTD |
PMID:34896196 |
|
NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,645,198...8,728,427
|
|
G
|
Mbd2
|
methyl-CpG binding domain protein 2
|
increases expression
|
ISO
|
Patulin results in increased expression of MBD2 mRNA
|
CTD |
PMID:38806716 |
|
NCBI chr18:64,174,002...64,240,795
Ensembl chr18:66,449,358...66,516,111
|
|
G
|
Mtor
|
mechanistic target of rapamycin kinase
|
multiple interactions decreases phosphorylation
|
ISO
|
Acetylcysteine inhibits the reaction [Patulin results in decreased phosphorylation of MTOR protein]
|
CTD |
PMID:29604266 |
|
NCBI chr 5:164,167,985...164,277,438
Ensembl chr 5:164,167,928...164,277,435
|
|
G
|
Ncf1
|
neutrophil cytosolic factor 1
|
increases expression
|
ISO
|
Patulin results in increased expression of NCF1 mRNA; Patulin results in increased expression of NCF1 protein
|
CTD |
PMID:33577942 |
|
NCBI chr12:28,121,816...28,131,080
Ensembl chr12:28,121,366...28,131,079
|
|
G
|
Nfe2l1
|
NFE2 like bZIP transcription factor 1
|
affects response to substance multiple interactions increases expression
|
ISO
|
NFE2L1 protein affects the susceptibility to Patulin NFE2L1 protein affects the reaction [Patulin results in increased expression of PSMA2 mRNA]; NFE2L1 protein affects the reaction [Patulin results in increased expression of PSMA5 mRNA]; NFE2L1 protein affects the reaction [Patulin results in increased expression of PSMA7 mRNA]; NFE2L1 protein affects the reaction [Patulin results in increased expression of PSMA8 mRNA]; NFE2L1 protein affects the reaction [Patulin results in increased expression of PSMC1 mRNA]; NFE2L1 protein affects the reaction [Patulin results in increased expression of PSMD2 mRNA]; NFE2L1 protein affects the reaction [Patulin results in increased expression of PSMD3 mRNA]; NFE2L1 protein affects the reaction [Patulin results in increased expression of PSMD4 mRNA] Patulin results in increased expression of NFE2L1 protein
|
CTD |
PMID:35367319 |
|
NCBI chr10:82,296,824...82,309,472
Ensembl chr10:82,292,508...82,309,375
|
|
G
|
Nlrp3
|
NLR family, pyrin domain containing 3
|
multiple interactions increases expression
|
ISO
|
3-methyladenine inhibits the reaction [Patulin results in increased expression of NLRP3 protein]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [Patulin results in increased expression of NLRP3 protein]
|
CTD |
PMID:33217525 |
|
NCBI chr10:44,826,299...44,853,373
Ensembl chr10:44,828,014...44,853,394
|
|
G
|
Ocln
|
occludin
|
increases degradation multiple interactions
|
ISO
|
Patulin results in increased degradation of OCLN protein 1,10-phenanthroline inhibits the reaction [Patulin results in increased degradation of OCLN protein]; Zinc Sulfate inhibits the reaction [Patulin results in increased degradation of OCLN protein]
|
CTD |
PMID:19013514 |
|
NCBI chr 2:33,391,303...33,442,207
Ensembl chr 2:33,391,303...33,430,411
|
|
G
|
Odc1
|
ornithine decarboxylase 1
|
increases activity
|
ISO
|
Patulin results in increased activity of ODC1 protein
|
CTD |
PMID:19000704 |
|
NCBI chr 6:40,329,831...40,336,444
Ensembl chr 6:46,058,463...46,065,146
|
|
G
|
Pik3cd
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
|
decreases expression
|
ISO
|
Patulin results in decreased expression of PIK3CD mRNA
|
CTD |
PMID:38806716 |
|
NCBI chr 5:165,377,994...165,426,620
Ensembl chr 5:165,377,994...165,403,968
|
|
G
|
Pmaip1
|
phorbol-12-myristate-13-acetate-induced protein 1
|
increases expression
|
ISO
|
Patulin results in increased expression of PMAIP1 mRNA
|
CTD |
PMID:21844328 |
|
NCBI chr18:62,255,970...62,262,384
Ensembl chr18:62,255,598...62,262,382
|
|
G
|
Ppp1r15a
|
protein phosphatase 1, regulatory subunit 15A
|
increases expression
|
ISO
|
Patulin results in increased expression of PPP1R15A mRNA; Patulin results in increased expression of PPP1R15A protein
|
CTD |
PMID:21844328 PMID:25577197 |
|
NCBI chr 1:96,000,053...96,003,128
Ensembl chr 1:105,136,525...105,139,774
|
|
G
|
Psma2
|
proteasome 20S subunit alpha 2
|
increases expression multiple interactions
|
ISO
|
Patulin results in increased expression of PSMA2 mRNA NFE2L1 protein affects the reaction [Patulin results in increased expression of PSMA2 mRNA]
|
CTD |
PMID:35367319 |
|
NCBI chr17:50,554,536...50,564,923
Ensembl chr17:55,247,442...55,339,673
|
|
G
|
Psma5
|
proteasome 20S subunit alpha 5
|
increases expression multiple interactions
|
ISO
|
Patulin results in increased expression of PSMA5 mRNA NFE2L1 protein affects the reaction [Patulin results in increased expression of PSMA5 mRNA]
|
CTD |
PMID:35367319 |
|
NCBI chr 2:195,896,369...195,919,733
Ensembl chr 2:198,584,505...198,607,867
|
|
G
|
Psma7
|
proteasome 20S subunit alpha 7
|
multiple interactions increases expression
|
ISO
|
NFE2L1 protein affects the reaction [Patulin results in increased expression of PSMA7 mRNA]
|
CTD |
PMID:35367319 |
|
NCBI chr 3:167,137,279...167,143,626
Ensembl chr 3:187,513,441...187,521,253
|
|
G
|
Psma8
|
proteasome 20S subunit alpha 8
|
multiple interactions increases expression
|
ISO
|
NFE2L1 protein affects the reaction [Patulin results in increased expression of PSMA8 mRNA]
|
CTD |
PMID:35367319 |
|
NCBI chr18:6,138,226...6,202,802
Ensembl chr18:6,138,226...6,202,802
|
|
G
|
Psmc1
|
proteasome 26S subunit, ATPase 1
|
increases expression multiple interactions
|
ISO
|
Patulin results in increased expression of PSMC1 mRNA NFE2L1 protein affects the reaction [Patulin results in increased expression of PSMC1 mRNA]
|
CTD |
PMID:35367319 |
|
NCBI chr 6:119,392,833...119,405,233
Ensembl chr 6:125,122,490...125,134,858
|
|
G
|
Psmd2
|
proteasome 26S subunit ubiquitin receptor, non-ATPase 2
|
increases expression multiple interactions
|
ISO
|
Patulin results in increased expression of PSMD2 mRNA NFE2L1 protein affects the reaction [Patulin results in increased expression of PSMD2 mRNA]
|
CTD |
PMID:35367319 |
|
NCBI chr11:80,248,364...80,258,991
Ensembl chr11:93,752,763...93,763,388
|
|
G
|
Psmd3
|
proteasome 26S subunit, non-ATPase 3
|
increases expression multiple interactions
|
ISO
|
Patulin results in increased expression of PSMD3 mRNA NFE2L1 protein affects the reaction [Patulin results in increased expression of PSMD3 mRNA]
|
CTD |
PMID:35367319 |
|
NCBI chr10:83,643,473...83,655,620
Ensembl chr10:84,139,677...84,151,878
|
|
G
|
Psmd4
|
proteasome 26S subunit ubiquitin receptor, non-ATPase 4
|
increases expression multiple interactions
|
ISO
|
Patulin results in increased expression of PSMD4 mRNA NFE2L1 protein affects the reaction [Patulin results in increased expression of PSMD4 mRNA]
|
CTD |
PMID:35367319 |
|
NCBI chr 2:185,287,941...185,297,238
Ensembl chr 2:185,286,868...185,297,201
|
|
G
|
Slc7a11
|
solute carrier family 7 member 11
|
increases expression multiple interactions
|
ISO
|
Patulin results in increased expression of SLC7A11 protein Patulin promotes the reaction [BECN1 protein modified form binds to SLC7A11 protein]
|
CTD |
PMID:35772596 |
|
NCBI chr 2:136,532,912...136,668,560
Ensembl chr 2:136,532,246...136,695,695
|
|
G
|
Smad2
|
SMAD family member 2
|
increases phosphorylation
|
EXP
|
Patulin results in increased phosphorylation of SMAD2 protein
|
CTD |
PMID:34896196 |
|
NCBI chr18:72,124,792...72,193,345
Ensembl chr18:72,124,863...72,187,388
|
|
G
|
Smad3
|
SMAD family member 3
|
increases phosphorylation
|
EXP
|
Patulin results in increased phosphorylation of SMAD3 protein
|
CTD |
PMID:34896196 |
|
NCBI chr 8:73,022,204...73,132,324
Ensembl chr 8:73,024,760...73,132,324
|
|
G
|
Smad4
|
SMAD family member 4
|
increases expression
|
EXP
|
Patulin results in increased expression of SMAD4 protein
|
CTD |
PMID:34896196 |
|
NCBI chr18:69,518,988...69,549,684
Ensembl chr18:69,518,988...69,549,684
|
|
G
|
Snai1
|
snail family transcriptional repressor 1
|
increases expression multiple interactions
|
EXP
|
Patulin results in increased expression of SNAI1 protein 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [Patulin results in increased expression of SNAI1 protein]
|
CTD |
PMID:34896196 |
|
NCBI chr 3:156,248,479...156,252,969
|
|
G
|
Snai2
|
snail family transcriptional repressor 2
|
increases expression
|
EXP
|
Patulin results in increased expression of SNAI2 protein
|
CTD |
PMID:34896196 |
|
NCBI chr11:99,686,934...99,690,349
Ensembl chr11:99,686,934...99,690,349
|
|
G
|
Sod1
|
superoxide dismutase 1
|
decreases response to substance
|
ISO
|
SOD1 protein results in decreased susceptibility to Patulin
|
CTD |
PMID:17090621 |
|
NCBI chr11:42,942,742...42,948,399
Ensembl chr11:42,942,678...42,948,399
|
|
G
|
Sqstm1
|
sequestosome 1
|
decreases expression multiple interactions
|
ISO
|
Patulin results in decreased expression of SQSTM1 protein Acetylcysteine inhibits the reaction [Patulin results in decreased expression of SQSTM1 protein]
|
CTD |
PMID:29604266 |
|
NCBI chr10:34,525,517...34,536,670
Ensembl chr10:35,026,598...35,037,750
|
|
G
|
Tgfb1
|
transforming growth factor, beta 1
|
increases expression multiple interactions
|
EXP
|
Patulin results in increased expression of TGFB1 protein 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [Patulin results in increased expression of TGFB1 protein]; Patulin promotes the reaction [FOS protein binds to TGFB1 promoter]; Patulin promotes the reaction [JUN protein binds to TGFB1 promoter]; Patulin results in increased expression of and results in increased secretion of TGFB1 protein; pyrazolanthrone inhibits the reaction [Patulin results in increased expression of TGFB1 protein]
|
CTD |
PMID:34896196 |
|
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:90,324,046...90,340,899
|
|
G
|
Tgfbr1
|
transforming growth factor, beta receptor 1
|
increases expression
|
EXP
|
Patulin results in increased expression of TGFBR1 protein
|
CTD |
PMID:34896196 |
|
NCBI chr 5:66,449,348...66,506,371
Ensembl chr 5:66,449,293...66,527,260
|
|
G
|
Tgfbr2
|
transforming growth factor, beta receptor 2
|
increases expression
|
EXP
|
Patulin results in increased expression of TGFBR2 protein
|
CTD |
PMID:34896196 |
|
NCBI chr 8:124,672,677...124,761,741
Ensembl chr 8:124,674,986...124,761,469
|
|
G
|
Timp1
|
TIMP metallopeptidase inhibitor 1
|
increases expression
|
EXP
|
Patulin results in increased expression of TIMP1 protein
|
CTD |
PMID:34896196 |
|
NCBI chr X:3,766,509...3,772,578
Ensembl chr X:3,766,510...3,771,135
|
|
G
|
Tjp1
|
tight junction protein 1
|
decreases expression
|
ISO
|
Patulin results in decreased expression of TJP1 protein
|
CTD |
PMID:19013514 |
|
NCBI chr 1:128,260,330...128,505,018
Ensembl chr 1:128,260,330...128,505,158
|
|
G
|
Tp53
|
tumor protein p53
|
increases expression
|
ISO
|
Patulin results in increased expression of TRP53; Patulin results in increased expression of TRP53 protein Patulin results in increased expression of TP53 protein
|
CTD |
PMID:19000704 PMID:19744505 PMID:26095701 |
|
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299
|
|
G
|
Vegfa
|
vascular endothelial growth factor A
|
increases expression
|
EXP
|
Patulin results in increased expression of VEGFA protein
|
CTD |
PMID:34896196 |
|
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194
|
|
G
|
Vim
|
vimentin
|
increases expression multiple interactions
|
EXP
|
Patulin results in increased expression of VIM protein 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [Patulin results in increased expression of VIM protein]
|
CTD |
PMID:34896196 |
|
NCBI chr17:81,577,261...81,585,746
Ensembl chr17:81,568,272...81,585,746
|
|
G
|
Xbp1
|
X-box binding protein 1
|
increases splicing
|
ISO
|
Patulin results in increased splicing of XBP1 mRNA
|
CTD |
PMID:21844328 PMID:25577197 |
|
NCBI chr14:80,390,629...80,395,713
Ensembl chr14:84,604,107...84,609,706
|
|
|
G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
multiple interactions
|
ISO
|
[Ryanodine co-treated with Halothane] results in increased expression of BAX mRNA
|
CTD |
PMID:32795494 |
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
|
|
G
|
Bcl2l11
|
Bcl2-like 11
|
multiple interactions
|
ISO
|
[Ryanodine co-treated with Halothane] results in increased expression of BCL2L11 mRNA
|
CTD |
PMID:32795494 |
|
NCBI chr 3:135,820,042...135,857,330
Ensembl chr 3:135,817,562...135,960,695
|
|
G
|
Casp3
|
caspase 3
|
multiple interactions
|
EXP
|
[Ryanodine co-treated with Thioctic Acid] results in decreased activity of CASP3 protein; Ryanodine inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein]
|
CTD |
PMID:17079870 |
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
G
|
Cat
|
catalase
|
multiple interactions
|
EXP
|
[bastadin 12 co-treated with Ryanodine co-treated with Dizocilpine Maleate] inhibits the reaction [tetrabromobisphenol A results in decreased activity of CAT protein]
|
CTD |
PMID:27718046 |
|
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526
|
|
G
|
Creb1
|
cAMP responsive element binding protein 1
|
multiple interactions
|
EXP
|
Ryanodine inhibits the reaction [Nicotine results in increased phosphorylation of CREB1 protein]
|
CTD |
PMID:21113126 |
|
NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:73,397,306...73,466,339
|
|
G
|
Cxcl2
|
C-X-C motif chemokine ligand 2
|
multiple interactions
|
ISO
|
Ryanodine promotes the reaction [Halothane results in increased expression of CXCL2 mRNA]
|
CTD |
PMID:32795494 |
|
NCBI chr14:17,465,210...17,467,255
Ensembl chr14:17,465,242...17,467,255
|
|
G
|
Ddit3
|
DNA-damage inducible transcript 3
|
multiple interactions
|
ISO
|
Ryanodine promotes the reaction [Halothane results in increased expression of DDIT3 mRNA]
|
CTD |
PMID:32795494 |
|
NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:65,005,501...65,006,509
|
|
G
|
Faslg
|
Fas ligand
|
multiple interactions
|
ISO
|
Ryanodine inhibits the reaction [FASL protein affects the localization of Calcium]
|
CTD |
PMID:20200208 |
|
NCBI chr13:76,680,885...76,706,042
Ensembl chr13:76,688,243...76,695,503
|
|
G
|
Fkbp1a
|
FKBP prolyl isomerase 1A
|
multiple interactions
|
ISO
|
Ryanodine promotes the reaction [Halothane results in increased expression of FKBP1A mRNA]
|
CTD |
PMID:32795494 |
|
NCBI chr 3:140,040,359...140,060,107
Ensembl chr 3:160,500,726...160,524,233
|
|
G
|
Fkbp1b
|
FKBP prolyl isomerase 1B
|
multiple interactions
|
ISO
|
[Ryanodine co-treated with Halothane] results in increased expression of FKBP1B mRNA; Ryanodine inhibits the reaction [FKBP1B gene mutant form inhibits the reaction [Acetylcholine affects the localization of and affects the abundance of Calcium]]
|
CTD |
PMID:17261647 PMID:32795494 |
|
NCBI chr 6:33,551,583...33,570,055
Ensembl chr 6:33,558,517...33,568,129
|
|
G
|
Gpt
|
glutamic--pyruvic transaminase
|
multiple interactions
|
ISO
|
Ryanodine promotes the reaction [Halothane results in increased expression of GPT protein]
|
CTD |
PMID:32795494 |
|
NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:110,296,206...110,300,160
|
|
G
|
Hmox1
|
heme oxygenase 1
|
multiple interactions
|
ISO
|
[Ryanodine co-treated with Halothane] results in increased expression of HMOX1 mRNA
|
CTD |
PMID:32795494 |
|
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
|
|
G
|
Homer1
|
homer scaffold protein 1
|
multiple interactions
|
ISO
|
Ryanodine promotes the reaction [Halothane results in increased expression of HOMER1 mRNA]
|
CTD |
PMID:32795494 |
|
NCBI chr 2:24,542,777...24,645,715
Ensembl chr 2:26,278,105...26,381,657
|
|
G
|
Il1b
|
interleukin 1 beta
|
multiple interactions
|
ISO
|
[Ryanodine co-treated with Halothane] results in increased expression of IL1B mRNA
|
CTD |
PMID:32795494 |
|
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
|
|
G
|
Itgam
|
integrin subunit alpha M
|
multiple interactions
|
ISO
|
Ryanodine promotes the reaction [Halothane results in increased expression of ITGAM mRNA]
|
CTD |
PMID:32795494 |
|
NCBI chr 1:192,089,496...192,139,947
Ensembl chr 1:192,089,542...192,139,943
|
|
G
|
Nr4a1
|
nuclear receptor subfamily 4, group A, member 1
|
multiple interactions
|
ISO
|
NR4A1 protein inhibits the reaction [Ryanodine inhibits the reaction [Colforsin results in increased expression of STAR protein]]; Ryanodine inhibits the reaction [Colforsin results in increased expression of NR4A1 mRNA]; Ryanodine inhibits the reaction [Colforsin results in increased expression of NR4A1 protein]
|
CTD |
PMID:23183170 |
|
NCBI chr 7:132,368,399...132,389,300
Ensembl chr 7:134,247,192...134,268,041
|
|
G
|
Plau
|
plasminogen activator, urokinase
|
multiple interactions
|
ISO
|
Ryanodine promotes the reaction [Mustard Gas results in increased activity of PLAU protein]
|
CTD |
PMID:9101041 |
|
NCBI chr15:3,505,485...3,511,987
Ensembl chr15:3,505,487...3,512,030
|
|
G
|
Ryr1
|
ryanodine receptor 1
|
multiple interactions
|
ISO
|
Triclosan promotes the reaction [Ryanodine binds to RYR1 protein] 2,3,6,2',3',6'-hexachlorobiphenyl affects the reaction [Ryanodine binds to RYR1 protein]; chlorantranilipole promotes the reaction [Ryanodine binds to RYR1 protein]; flubendiamide promotes the reaction [Ryanodine binds to RYR1 protein]
|
CTD |
PMID:18795164 PMID:18954145 PMID:30329129 |
|
NCBI chr 1:84,292,578...84,423,824
Ensembl chr 1:93,420,078...93,551,305
|
|
G
|
Ryr2
|
ryanodine receptor 2
|
affects binding multiple interactions
|
ISO EXP
|
Ryanodine binds to RYR2 protein 2,3,6,2',3',6'-hexachlorobiphenyl affects the reaction [Ryanodine binds to RYR2 protein] decamethrin promotes the reaction [Ryanodine binds to RYR2 protein]
|
CTD |
PMID:11278295 PMID:18954145 PMID:31166131 |
|
NCBI chr17:58,389,925...58,975,641
Ensembl chr17:63,081,527...63,666,705
|
|
G
|
S100a8
|
S100 calcium binding protein A8
|
multiple interactions
|
ISO
|
Ryanodine promotes the reaction [Halothane results in increased expression of S100A8 mRNA]
|
CTD |
PMID:32795494 |
|
NCBI chr 2:178,464,095...178,465,223
Ensembl chr 2:178,464,702...178,465,221
|
|
G
|
S100a9
|
S100 calcium binding protein A9
|
multiple interactions
|
ISO
|
Ryanodine promotes the reaction [Halothane results in increased expression of S100A9 mRNA]
|
CTD |
PMID:32795494 |
|
NCBI chr 2:178,487,941...178,490,622
Ensembl chr 2:178,487,941...178,490,870
|
|
G
|
Star
|
steroidogenic acute regulatory protein
|
multiple interactions
|
ISO
|
NR4A1 protein inhibits the reaction [Ryanodine inhibits the reaction [Colforsin results in increased expression of STAR protein]]; Ryanodine inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of STAR mRNA]; Ryanodine inhibits the reaction [Colforsin results in increased expression of STAR mRNA]; Ryanodine inhibits the reaction [Colforsin results in increased expression of STAR protein]
|
CTD |
PMID:23183170 |
|
NCBI chr16:72,969,824...72,974,447
Ensembl chr16:72,961,518...72,974,447
|
|
G
|
Tnf
|
tumor necrosis factor
|
multiple interactions
|
ISO
|
Ryanodine promotes the reaction [Halothane results in increased expression of TNF mRNA]
|
CTD |
PMID:32795494 |
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
G
|
Vcam1
|
vascular cell adhesion molecule 1
|
multiple interactions
|
ISO
|
Ryanodine promotes the reaction [Halothane results in increased expression of VCAM1 mRNA]
|
CTD |
PMID:32795494 |
|
NCBI chr 2:206,723,050...206,742,783
Ensembl chr 2:206,723,044...206,742,801
|
|
|
G
|
F2
|
coagulation factor II, thrombin
|
increases chemical synthesis multiple interactions increases abundance
|
ISO
|
F2 protein results in increased chemical synthesis of Thromboxane B2 Indomethacin inhibits the reaction [F2 protein results in increased abundance of Thromboxane B2]; N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [F2 protein results in increased abundance of Thromboxane B2]
|
CTD |
PMID:10027849 PMID:16293890 |
|
NCBI chr 3:98,051,958...98,065,246
Ensembl chr 3:98,051,960...98,065,246
|
|
G
|
Il1b
|
interleukin 1 beta
|
increases abundance multiple interactions
|
ISO
|
IL1B protein results in increased abundance of Thromboxane B2 Triamcinolone Acetonide inhibits the reaction [IL1B protein results in increased abundance of Thromboxane B2]
|
CTD |
PMID:15337628 |
|
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
|
|
G
|
Il4
|
interleukin 4
|
multiple interactions
|
ISO
|
[Poly I-C co-treated with IL4 protein] results in increased secretion of Thromboxane B2; amorolfine inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in increased secretion of Thromboxane B2]; butenafine inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in increased secretion of Thromboxane B2]; Itraconazole inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in increased secretion of Thromboxane B2]; Ketoconazole inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in increased secretion of Thromboxane B2]; luliconazole inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in increased secretion of Thromboxane B2]; Terbinafine inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in increased secretion of Thromboxane B2]
|
CTD |
PMID:23688403 |
|
NCBI chr10:38,272,003...38,277,549
Ensembl chr10:38,272,003...38,277,549
|
|
G
|
Pla2g2a
|
phospholipase A2 group IIA
|
increases abundance multiple interactions
|
ISO
|
PLA2G2A protein results in increased abundance of Thromboxane B2 varespladib inhibits the reaction [PLA2G2A protein results in increased abundance of Thromboxane B2]
|
CTD |
PMID:10027849 |
|
NCBI chr 5:156,359,725...156,362,302
Ensembl chr 5:156,359,725...156,362,297
|
|
G
|
Ptgs1
|
prostaglandin-endoperoxide synthase 1
|
multiple interactions
|
ISO
|
[PTGS1 protein results in increased metabolism of Arachidonic Acid] which results in increased chemical synthesis of Thromboxane B2; arzanol inhibits the reaction [[PTGS1 protein results in increased metabolism of Arachidonic Acid] which results in increased chemical synthesis of Thromboxane B2] [N-caffeoyldopamine results in decreased activity of PTGS1 protein] which results in decreased abundance of Thromboxane B2
|
CTD |
PMID:17319684 PMID:20933508 |
|
NCBI chr 3:39,981,419...40,002,993
Ensembl chr 3:39,981,415...40,002,990
|
|
G
|
Ptgs2
|
prostaglandin-endoperoxide synthase 2
|
multiple interactions
|
ISO
|
2-(4-chloro-6-(2,3-dimethylphenylamino)pyrimidin-2-ylthio)octanoic acid inhibits the reaction [[Lipopolysaccharides results in increased activity of PTGS2 protein] which results in increased chemical synthesis of Thromboxane B2]; [L 745337 results in decreased activity of PTGS2 protein] which results in decreased chemical synthesis of Thromboxane B2; [lipopolysaccharide, E. coli O26-B6 results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Thromboxane B2; [Lipopolysaccharides results in increased activity of PTGS2 protein] which results in increased chemical synthesis of Thromboxane B2; [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Thromboxane B2 [N-caffeoyldopamine results in decreased activity of PTGS2 protein] which results in decreased abundance of Thromboxane B2; [PTGS2 gene mutant form results in increased susceptibility to Kainic Acid] which results in increased abundance of Thromboxane B2; [PTGS2 gene mutant form results in increased susceptibility to Nanotubes, Carbon] which results in increased abundance of Thromboxane B2
|
CTD |
PMID:8621535 PMID:17319684 PMID:18834901 PMID:19934399 PMID:23642096 |
|
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320
|
|
G
|
Tbxas1
|
thromboxane A synthase 1
|
multiple interactions
|
ISO
|
[Sulfasalazine results in decreased activity of TBXAS1 protein] which results in decreased chemical synthesis of Thromboxane B2
|
CTD |
PMID:2572437 |
|
NCBI chr 4:67,664,963...67,837,096
Ensembl chr 4:68,631,838...68,803,969
|
|
G
|
Tnf
|
tumor necrosis factor
|
multiple interactions increases abundance increases secretion
|
ISO
|
1-carboxyheptylimidazole inhibits the reaction [TNF protein results in increased secretion of Thromboxane B2]; cyanidin-3-O-beta-glucopyranoside inhibits the reaction [TNF protein results in increased abundance of Thromboxane B2]; Ketoconazole inhibits the reaction [TNF protein results in increased secretion of Thromboxane B2]; Terbinafine inhibits the reaction [TNF protein results in increased secretion of Thromboxane B2]; wedelolactone inhibits the reaction [TNF protein results in increased abundance of Thromboxane B2]
|
CTD |
PMID:16784723 PMID:27793764 |
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|